Books by Subject
- Achieving an AIDS transition : preventing infections to sustain treatment — Handbook of meningococcal disease management (100)
- HCV infection and cryoglobulinemia — New and evolving infections of the 21st century (100)
- New frontiers of molecular epidemiology of infectious diseases — World malaria report 2009 (79)
- 2011 ebraryMead Over.The global AIDS transition: a feasible objective for AIDS policy -- Using incentives to prevent HIV infections -- Sustaining and leveraging AIDS treatment -- Appendix A. Alternative approaches to estimating the average cost of antiretroviral treatment -- Appendix B. A meta-analysis of the health benefits of early initiation of antiretroviral therapy -- Appendix C. A model for projecting future AIDS treatment costs.
- 2014 Springer Protocolsedited by Miguel Chillón, Assumpció Bosch.Biophysical methods to monitor structural aspects of the adenovirus infectous cycle / Rosa Menéndez-Conejero ... [et al.] -- Proteome analysis of adenovirus using mass spectrometry / Sara Bergström Lind, Konstantin A. Artemenko, and Ulf Pettersson -- Capsid modification strategies for detargeting adenoviral vectors / Alan L. Parker ... [et al.] -- Use of dodecahedron "VLPs" as an alternative to the whole adenovirus / Pascal Fender -- Study of adenovirus and CAR axonal transport in primary neurons / Charleine Zussy and Sara Salinas -- The use of chromatin immunoprecipitation (hIP) to study the binding of viral proteins to the adenovirus genome in vivo / Yueting Zheng and Patrick Hearing -- DNA microarray to analyze adenovirus-host interactions / Stefania Piersanti, Enrico Tagliafico, and Isabella Saggio -- Determination of the transforming activities of adenovirus oncogenes / Thomas Speiseder, Michael Nevels, and Thomas Dobner -- Oncolytic adenovirus characterization : activity and immune responses / Raul Gil-Hoyos, Juan Miguel-Camacho, and Ramon Alemany -- The analysis of innate immune response to adenovirus using antibody arrays / Nelson C. Di Paolo and Dmitry M. Shayakhmetov -- Engineering adenovirus genome by bacterial artificil chromosome (BAC) technology / Zsolt Ruzsics, Frederic Lemnitzer, and Christian Thirion -- Construction, production, and purification of recombinant adenovirus vectors / Susana Miravet ... [et al.] -- Sealable production of adenovirus vectors / Ana Carina Silva ... [et al.] -- Canine adenovirus downstream processing protocol / Meritxell Puig ... [et al.] -- Production of high-capacity adenovirus vectors / Florian Kreppel -- Production of chimeric adenovirus / Marta Miralles ... [et al.]
- 2016 SpringerGianfranco Donelli, editor.Imported and indigenous cases of invasive meningococcal disease W:P1.5,2:F1-1:ST-11: the migration link. Italy, June-November 2014, Paola Stefanelli*, Cecilia Fazio, Arianna Neri, Giovanni Rezza, Santino Severoni, Paola Vacca, Teresa Fasciana, Alessandro Bisbano, Francesca Di Bernardo and Anna Giammanco -- Partial protection induced by 2011-2012 influenza vaccine against serologically evidenced A(H3N2) influenza virus infections in elderly institutionalized people, Barbara Camilloni, Michela Basileo, Giuseppe Menculini, Paolo Tozzi, Anna Maria Iorio* -- Fungal occurrence in the hair and skin of symptomatic pets in Turin, Italy, Valeria Allizond, Vivian Tullio, Anna Maria Cuffini*, Janira Roana, Daniela Scalas, Elisa Simona Marra, Giorgia Piersigilli, Narcisa Mandras, Giuliana Banche -- Infectious agents associated with head and neck carcinomas, Andrea Hettmann, Anett Demcsák, Gábor Decsi, Ádám Bach, Dóra Pálinkó,László Rovó, Katalin Nagy, Mária Takács, Janos Minarovits* -- Increase in peripheral CD3-CD56brightCD16- natural killer cells in Hashimoto's thyroiditis associated with HHV-6 infection, Roberta Rizzo*, Maria Chiara Zatelli, Antonella Rotola, Enzo Cassai, Ettore Degli Uberti, Dario Di Luca, Elisabetta Caselli -- In vitro and in vivo biofilm wound models and their application -- Gilles Brackman* and Tom Coenye -- The Lactobacillus plantarum Eno A1 enolase is involved in immunostimulation of Caco-2 cells and in biofilm development, Valeria Vastano, Annunziata Pagano, Alessandra Fusco, Gianluca Merola, Margherita Sacco, Giovanna Donnarumma* -- Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis, Oliva A, Pavone P, D'Abramo A, Iannetta M, Mastroianni CM, Vullo V -- The isolation, identification and analyses of Lactobacillus genus bacteria with probiotic potential, Tatiana A. Cherdyntseva, Irina B. Kotova and Alexander I. Netrusov -- In vitro activity of tigecycline against Acinetobacter baumannii: Global epidemiology and resistance mechanisms -- Spyros Pournaras, Vasiliki Koumaki, Vasiliki Gennimata, Evangelia Kouskouni, and AthanassiosTsakris.Also available: Print – 2016
- 2015 Wiley[edited by] Dongmei Chen, Bernard Moulin, Jianhong Wu.Introduction to analyzing and modeling spatial and temporal dynamics of infectious diseases / Dongmei Chen, Bernard Moulin, Jianhong Wu -- Modeling the spread of infectious diseases : a review / Dongmei Chen -- West Nile virus : a narrative from bioinformatics and mathematical modeling studies / U.S.N. Murty, Amit Kumar Banerjee and Jianhong Wu -- West Nile virus risk assessment and forecasting using statistical and dynamical models / Ahmed Abdelrazec, Yurong Cao, Xin Gao, Paul Proctor, Hui Zheng, and Huaiping Zhu -- Using mathematical modeling to integrate disease surveillance and global air transportation data / Julien Arino and Kamran Khan -- Mathematical modeling of malaria models with spatial effects / Daozhou Gao and Shigui Ruan -- Avian influenza spread and transmission dynamics / Lydia Bourouiba, Stephen Gourley, Rongsong Liu, John Takekawa, and Jianhong Wu -- Analyzing the potential impact of bird migration on the global spread of H5N1 avian influenza (2007-2011) using spatio-temporal mapping methods / Heather Richardson and Dongmei Chen -- Cloud computing-enabled cluster detection using a flexibly shaped scan statistic for real-time syndromic surveillance / P. Belanger and K. Moore -- Mapping the distribution of malaria : current approaches and future directions / L.R. Johnson, K.D. Lafferty, A. McNally, E. Mordecai, K. Paaijmans, S. Pawar, S.J. Ryan -- Statistical modeling of spatio-temporal infectious disease transmission / Rob Deardon, Xuan Fang and Grace Pui Sze Kwong -- Spatio-temporal dynamics of schistosomiasis in China : bayesian-based geostatistical analysis / Zhi-Jie Zhang -- Spatial analysis and statistical modeling of 2009 H1N1 pandemic in the greater Toronto area / Frank Wen, Dongmei Chen, Anna Majury -- West Nile virus mosquito abundance modeling using a non-stationary spatio-temporal geostatistics / Eun-Hye Yoo, Dongmei Chen, Curtis Russel -- Spatial pattern analysis of multivariate disease data / Cindy X. Feng and Charmaine Dean -- The zoonosismags project (part 1) : population-based geosimulation of zoonoses in an informed virtual geographic environment / Bernard Moulin, Mondher Bouden, Daniel Navarro -- Zoonosismags project (part 2) : complementarity of a rapid-propotyping tool and of a full-scale geosimulator for population-based geosimulation of zoonoses / Bernard Moulin, Daniel Navarro, Dominic Marcotte, Said Sedrati -- Web-mapping and behaviour pattern extraction tools to assess lyme disease risk for humans in peri-urban forests / Hedi Haddad, Bernard Moulin, Franck Manirakiza Christelle Maha, Vincent Godard and Samuel Mermet -- An integrated approach for communicable disease geosimulation based on epidemiological, human mobility and public intervention models / Hedi Haddad, Bernard Moulin, Marius Thariault -- Smartphone trajectories as data sources for agent-based infection spread modeling / M.R. Friesen and R.D. McLeod.
- 2014 Springer Protocolsedited by Erica Spackman, Exotic and Emerging Avia Viral Diseases Unit, Southeast Poultry Research Laboratory, US Department of Agriculture, Agricultural Research Service, Athens, GA, USA.Hemagglutination assay for influenza virus / Mary Lea Killian -- Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus / Janice C. Pedersen -- Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity / Janice C. Pedersen -- Reverse genetics of influenza virus / Chang-Won Lee -- Immunohistochemical staining of influenza virus in tissues / Mary J. Pantin-Jackwood -- A brief introduction to avian influenza virus / Erica Spackman -- Wild bird surveillance for avian influenza virus / Justin D. Brown, Rebecca Poulson, and David E. Stallknecht -- Avian influenza virus sample types, collection, and handling / Mary Lea Killian -- Avian influenza virus RNA extraction / Erica Spackman and Scott A. Lee -- Avian influenza virus detection and quantitation by real-time RT-PCR / Erica Spackman -- Influenza subtype identification with molecular methods / Erica Spackman -- Avian influenza virus isolation, propagation, and titration in embryonated chicken eggs / Erica Spackman and Mary Lea Killian -- Agar gel immunodiffusion assay to detect antibodies to type A influenza virus / Terra A. Jenson -- Detection of influenza A antibodies in avian serum samples by ELISA / Len Chappell, Mary Lea Killian, and Erica Spackman -- Conducting influenza virus pathogenesis studies in avian species / Carol J. Carona [and three others] -- Laboratory methods for assessing and licensing influenza vaccines for poultry / David E. Swayne -- Detection of cell-mediated immune response to avian influenza viruses / Darrell R. Kapczynski -- Characterization of cytokine expression induced by avian influenza virus infection with realt-time RT-PCR / Darrell R. Kapczynski, Hai Jun Jiang, and Michael H. Kogut -- Newcastle disease virus detection and differentiation from avian influenza / Patti J. Miller and Mia Kim Torchetti -- A brief introduction to influenza A virus in swine / Amy L. Vincent, Kelly M. Lager, and Tavis K. Anderson -- Sample types, collection, and transport for influenza A viruses of swine / Marie R. Culhane and Susan E. Detmer -- Isolation of swine influenza virus in cell cultures and embryonated chicken eggs / Jianqiang Zhang and Phillip C. Gauger -- RNA extraction from swine samples and detection of influenza A virus in swine by real-time RT-PCR / Jianqiang Zhang and Karen M. Harmon -- Hemagglutinin inhibition assay with swine sera / Pravina Kitikoon, Phillip C. Gauger, and Amy L. Vincent -- Enzyme-linked immunosorbent assay for detection of serum or mucosal isotype-specific IgG and IgA whole-virus antibody to influenza A virus in swine / Phillip C. Gauger, Crystal L. Loving, and Amy L. Vincent -- Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine / Phillip C. Gauger and Amy L. Vincent -- Microneutralization assay for swine influenza virus in swine serum / Pravina Kitikoon and Amy L. Vincent -- Analyzing swine sera for functional antibody titers against influenza A neuraminidase proteins using an enzyme-linked lectin assay (ELLA) / Matthew R.Sandbulte and Maryna C. Eichelberger -- Antibody secreting cell assay for influenza A virus in swine / Pravina Kitikoon, Crystal L. Loving, and Amy L. Vincent -- In vivo models for pathotyping and vaccine efficacy for swine influenza / Kelly M. Lager and Amy L. Vincent -- A brief introduction to equine influenza and equine influenza viruses / Thomas M. Chambers -- Equine influenza diagnosis : sample collection and transport / Thomas M. Chambers and Stephanie E. Reedy -- RNA extraction from equine samples for equine influenza virus / Udeni B.R. Balasuriya -- Type A influenza virus detection from horses by real-time RT-PCR and insulated isothermal RT-PCR / Udeni B.R. Balasuriya -- Equine influenza culture methods / Thomas M. Chambers and Stephanie E. Reedy -- Equine influenza serological methods / Thomas M. Chambers and Stephanie E. Reedy.
- 2012 WHOedited by Al Dufour, Jamie Bartram, Robert Bos and Victor Gannon.Also available: Print – 2012
- 2011 SpringerIan M. Gould, Jos W.M. van der Meer, editors.
- 2012 OvidFinch, R. G.Pt. 1. General properties of antimicrobial agents -- Pt. 2. Resistance to antimicrobial agents -- Pt. 3. General principles of usage of antimicrobial agents -- Pt. 4. Therapeutic use of antimicrobial agents.
- v. 1-2, 2009. Springerv. 2, 2009 Springeredited by Douglas Mayers ; section editors, Stephen A. Lerner, Marc Ouellette, Jack D. Sobel.v. 1. Mechanisms of drug resistance -- v. 2. Clinical and epidemiological aspects.
- 2010 Kargervolume editor, J. Todd Weber.Community-associated methicillin resistant staphylococcus aureus / Miller, L.G. -- Infections with organisms producing extended-spectrum [beta]-lactamase / Paterson, D.L., Doi, Y. -- Fluoroquinolone resistance : challenges for disease control / Parry, C.M. -- Antibiotic resistance and community-acquired pneumonia during an influenza pandemic / Moore, M.R., Whitney, C.G. -- Promoting appropriate antimicrobial drug use in the outpatient setting : what works? / Belongia, E.A., Mangione-Smith, R., Knobloch, M.J. -- Reducing antimicrobial-resistant infections in health care settings : what works? / Rezai, K., Weinstein, R.A. -- Cost of antimicrobial resistance in healthcare settings : a critical review / Merz, L.R., Guth, R.M., Fraser, V.J. -- Mass treatment of parasitic disease : implications for the development and spread of anthelmintic resistance / Curcher, T.S. ... [et al.] -- Antifungal drug resistance : clinical importance, in vitro detection and implications for prophylaxis and treatment / Arthington-Skaggs, B.A., Frade, J.P. -- Preparing for HIV drug resistance in the developing world / Bennett, D.E.
- 2008 SpringerI.W. Fong, Karl Drlica, editors.Mechanisms of resistance by gram-positive bacteria (streptococci and enterococci) / Javier Aspa Marco ... [et al.] -- Emergence of MRSA in the community / Adam L. Cohen, Rachel Gorwitz, and Daniel B. Jernigan -- Antimicrobial resistance to sexually transmitted infections / Hillard Weinstock, David Trees, and John Papp -- Resistance of gram-negative bacilli to antimicrobials / Patricia A. Bradford and Charles R. Dean -- Mycobacterial antimicrobial resistance / Peter D.O. Davies and Richard Cooke -- Antimicrobial resistance of anaerobic bacteria / Ellie J.C. Goldstein, Diane M. Citron, and David W. Hecht -- Clinical significance and biological basis of HIV drug resistance / Jorge L. Martinez-Cajas, Marco Petrella, and Mark A. Wainberg -- Resistance of herpesviruses to antiviral agents / G. Boivin and W.L. Drew -- Hepatitis virus resistance / Jean-Michel Pawlotsky -- Resistance to antifungal agents / Beth A. Arthington-Skaggs and John H. Rex -- An anti-mutant approach for antimicrobial use / Karl Drlica ... [et al.]
- 2010 SpringerAníbal de J. Sosa, Denis K. Byarugaba, Carlos F. Amábile-Cuevas, Po-Ren Hsueh, Samuel Kariuki, Iruka N. Okeke, editors ; foreword by Thomas F. O'Brien ; introductory preface by the editors ; guest preface by Stuart B. Levy.General issues in antimicrobial resistance -- Global perspectives of antibiotic resistance -- Mechanisms of antimicrobial resistance -- Poverty and root causes of resistance in developing countries -- What the future holds for resistance in developing countries -- Introduction of antimicrobial agents in resource-constrained countries: impact on the emergence of resistance -- Human impact of resistance -- Human immunodeficiency virus: resistance to antiretroviral drugs in developing countries -- Drug resistance in malaria in developing countries -- Drug resistance in Mycobacterium tuberculosis -- Antifungal drug resistance in developing countries -- Drug resistance in African trypanosomiasis -- Antimicrobial resistance in enteric pathogens in developing countries -- Bacterial-resistant infections in resource-limited countries -- Prevalence of resistant enterococci in developing countries -- Antimicrobial resistance in gram-negative bacteria from developing countries -- Resistance in reservoirs and human commensals -- Antimicrobial use and misuse -- Determinants of antimicrobial use: poorly understood-poorly researched -- Antimicrobial use and resistance in Africa -- Antimicrobial drug resistance in Asia -- Antimicrobial drug resistance in Latin American and the Caribbean -- Hospital infections by antimicrobial-resistant organisms in developing countries -- Cost, policy, and regulation of antimicrobials -- Economic burden of antimicrobial resistance in the developing world -- Strengthening health systems to improve access to antimicrobials and the containment of resistance -- Role of unregulated sale and dispensing of antimicrobial agents on the development of antimicrobial resistance in developing countries -- Counterfeit and substandard anti-infectives in developing countries -- Strategies to contain antimicrobial resistance -- Containment of antimicrobial resistance in developing countries and lessons learned -- Surveillance of antibiotic resistance in developing countries: needs, constraints and realities -- Vaccines: a cost-effective strategy to contain antimicrobial resistance -- Teaching appropriate antibiotic use in developing countries -- Containing global antibiotic resistance: ethical drug promotion in the developing world -- News media reporting of antimicrobial resistance in Latin America and India.
- 2014 SpringerFlavia Marinelli, Olga Genilloud, editors.Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the "arms race" with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
- 2012 Wileyedited by Heiman F.L. Wertheim, Peter Horby, John P. Woodall.Section 1. Infectious disease drivers -- Section 2. Bacterial infections -- Section 3. Fungal infections -- Section 4. Parasitic infections -- Section 5. Viral infections -- Index.
- 2008 Kargervolume editors, H.-D. Klenk, M.N. Matrosovich, J. Stech.Epidemiology of avian influenza / Osterhaus, A.D.M.E., Munster, V.J., Fouchier, R.A.M. -- H5N1 in Asia / Yen, H.-L. ... [et al.] -- Epidemiology and control of H5N1 avian influenza in China / Chen, H., Bu, Z., Wang, J. -- Avian influenza in Northern Eurasia / Lvov, D.K., Kaverin, N.V. -- Avian influenza in Italy, 1997-2006 / Capua, I. ... [et al.] -- Avian influenza outbreaks in Germany : development of new avian vaccines / Werner, O. ... [et al.] -- The role of pigs in interspecies transmission / Brown, I.H. -- History of research on avian influenza / Scholtissek, C. -- Reverse genetics of influenza viruses : applications in research and vaccine design / Neumann, G., Horimoto, T., Kawaoka, Y. -- Receptor specificity of influenza viruses and its alteration during interspecies transmission / Matrosovich, M.N., Gambaryan, A.S., Klenk, H.-K. -- Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis / Garten, W., Klenk, H.-D. -- Structure and function of the influenza A virus ribonucleoprotein : transcription and replication / Ortín, J. -- Influenza A virus polymerase : a determinant of host range and pathogenicity / Stech, J. -- Influenza A virus virulence and innate immunity : recent insights from new mouse models / Haller, O., Kochs, G., Staeheli, P. -- Signaling to life and death : influenza viruses and intracellular signal transduction cascades / Ludwig, S. ... [et al.] -- Cytokines in the pathogenesis of highly virulent influenza viruses in humans / Van Reeth, K. -- Antivirals and resistance / Hay, A.J., Collins, P.J., Russell, R.J. -- The 1918 influenza pandemic : lessons from the past raise questions for the future / Steel, J., Palese, P.
- 2009 SpringerIlaria Capua, Dennis J. Alexander, editors.
- 2006 Springeredited by Voon L. Chan, Philip M. Sherman, Billy Bourke.Microbial genomes / Voon Loong Chan -- Evolution and origin of virulence isolates / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Genomic approach to understanding of infectious disease mechanisms / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Knockout and disease models in toll-like receptor-mediated immunity / Huey-Lan Huang and Wen-Chen Yeh -- Campylobacter from glycome to pathogenesis / John Kelly ... [et al.] -- Genomics of helicobacter species / Zhongming Ge and David B. Schauer -- The organization of leptospira at a genomic level / Dieter M. Bulach ... [et al.] -- Listeria monocytogenes / Keith Ireton -- Mycobacterial genomes / David C. Alexander and Jun Liu -- Mycoplasma / Yuko Sasaki -- Genome comparisons of diverse staphylococcus aureus strains / Martin J. McGavin -- Type III secretion, systems in yersinia pestis, and yersinia pseudotuberculosis / James B. Bliska, Michelle B. Ryndak, and Jens P. Grabenstein -- Genomics and the evolution of pathogenic vibrio cholerae / William S. Jermyn ... [et al.] -- Future directions of infectious disease research / Philip M. Sherman, Billy Bourke, and Voon Loong Chan -- Index.Also available: Print – 2006
- 2009 Springeredited by Philip S. Brachman and Elias Abrutyn.Epidemiological concepts / Alfred S. Evans -- Public health surveillance / Philip S. Brachman -- Molecular epidemiology / Lee W. Riley -- Epidemiology of bacterial resistance to antimicrobial agents / Fred C. Tenover and John E. McGowan, Jr. -- Anthrax / Philip S. Brachman and Arnold F. Kaufmann -- Bacterial foodborne disease / Heather Green ... [et al.] -- Botulism / Patricia A. Yu ... [et al.] -- Brucellosis / Edward J. Young -- Campylobacter infections / Ban Mishu Allos -- Chancroid / Jaffar A. Al-Tawfiq -- Chlamydial infections / Julius Schachter and E. Russell Alexander -- Cholera / Manoj P. Menon, Eric D. Mintz, and Robert V. Tauxe -- Clostridium difficile / Dale N. Gerding and Stuart Johnson -- Dipththeria / Melinda Wharton -- Escherichia coli diarrhea / Herbert L. DuPont, M. Teresa Estrada-Garcia, and Zhi-Dong Jiang -- Gonococcal infections / Jonathan M. Zenilman and J. McLeod Griffiss -- Haemophilus influenzae / Janet R. Gilsdorf -- Helicobacter pylori / Sharon Perry, Catherine de Martel, and Julie Parsonnet -- Legionellosis / Roopal Patel, Matthew R. Moore, and barry S. Fields -- Leprosy / Richard I. Frankel and David M. Scollard -- Leptospirosis / Paul N. Levett and Charles N. Edwards -- Listeria monocytogenes infections / Donald Armstrong and Donald B. Louria -- Lyme disease / Roger P. Clark and Linden T. Hu -- Meningococcal infections / Robert S. Baltimore -- Mycoplasma pneumoniae and other human mycoplasmas / Deborah F. Talkington and Ken B. Waites -- Healthcare-acquired bacterial infections / Ebbing Lautenbach and Elias Abrutyn -- Pertussis / Scott A. Halperin and Gaston De Serres -- Plague / David T. Dennis and J. Erin Staples -- Pneumococcal infections / Keith P. Klugman and Charles Feldman -- Q fever / Thomas J. Marrie -- Rocky mountain spotted fever / Aaron Milstone and J. Stephen Dumler -- Salmonellosis : nontyphoidal / Michael F. Lynch and Robert V. Tauxe -- Shigellosis / Gerald T. Keusch -- Evans' infections of humans: staphylococcal infections / Zeina A. Kanafani and Vance G. Fowler, Jr. -- Streptococcal infections / Barry M. Gray and Dennis L. Stevens -- Syphilis / Anne Rompalo and Willard Cates -- Nonvenereal treponematoses / Ammar M. Ahmed ... [et al.] -- Tetanus / Steven G.F. Wassilak and Katrina Kretsinger -- Toxic shock syndrome (staphylococcal) / Arthur L. Reingold -- Tuberculosis / Diana S. Pope, Richard E. Chaisson, and George W. Comstock -- Nontuberculous mycobacterial infections / Charles L. Daley -- Tularemia / Paul S. Mead and Jeannine M. Petersen -- Typhoid fever / Myron M. Levine -- Yersinia enterocolitica infections / Ann M. Schmitz and Robert V. Tauxe.Also available: Print – 2009
- 2014 Ovideditor, William R. Jarvis, President, Jason and Jarvis Associates, LLC, Port Orford, Oregon, Hilton Head Island, South Carolina, San Francisco, California.Section I General Considerations of Hospital Infections -- 1. Epidemiology of Healthcare-Associated Infections / Belinda Ostrowsky -- 2. The Healthcare Epidemiologist / Bryan P. Simmons -- 3. Hand Hygiene / Didier Pittet -- 4. Occupational Health Services / Elizabeth A. Bolyard -- 5. The Development of Infection Surveillance and Prevention Programs / Keith F. Woeltje -- 6. Surveillance of Healthcare-Associated Infections / Robert P. Gaynes -- 7. The Use of Prevalence Surveys for Healthcare-Associated Infections Surveillance / Bruno P. Coignard -- 8. Investigating Endemic and Epidemic Healthcare-Associated Infections / William R. Jarvis -- 9. Epidemiologic Methods for Investigating Infections in the Healthcare Setting / Ebbing Lautenbach -- 10. Use of Computerized Systems in Healthcare Epidemiology / Keith F. Woeltje -- 11. The Role of the Laboratory in Prevention of Healthcare-Associated Infections / Daniel J. Diekema -- 12. The Practice of Epidemiology in Community Hospitals / August J. Valenti -- 13. The Role of Professional, Governmental, and Regulatory Organizations in Infection Prevention and Control / Tammy S. Lundstrom -- 14. Antimicrobial Stewardship: Programmatic Efforts to Optimize Antimicrobial Use / William R. Jarvis -- 15. Multidrug-Resistant Organisms: Epidemiology and Control / Mary K. Hayden -- 16. Molecular Biology of Resistance: A Brief History of Resistance Mechanisms and the Discovery of Gene Transfer / Robert A. Bonomo -- 17. Economic Evaluation of Healthcare-Associated Infections and Infection-Control and Antimicrobial-Stewardship Interventions / Sara E. Cosgrove -- 18. Epidemiology and Control of Healthcare-Acquired Infections in Limited-Resource Settings / Victor D. Rosenthal -- Section II Functional Areas of Concern -- 19. The Inanimate Environment / John M. Boyce -- 20. Disinfection and Sterilization in Healthcare Facilities / David J. Weber -- 21. Foodborne Disease Prevention in Healthcare Facilities / Susan Springthorpe -- 22. Clinical Laboratory---Acquired Infections / L. Barth Reller -- 23. Dialysis-Associated Complications and Their Control / Priti R. Patel -- 24. The Intensive Care Unit, Part A: HAI Epidemiology, Risk Factors, Surveillance, Engineering and Administrative Infection Control Practices, and Impact / Stephan A. Harbarth -- 25. The Intensive Care Unit, Part B: Antibiotic Resistance and Prevention of CVC-BSIs, Catheter-Associated Urinary Tract Infections, and C. difficile / Dennis G. Maki -- 26. The Newborn Nursery and the Neonatal Intensive Care Unit / Nalini Singh -- 27. The Perioperative Suite / Sharon Giarrizzo-Wilson -- 28. Ambulatory Care Settings / Kathleen H. Petersen -- 29. Infections in Long-Term Care Facilities / Chesley L. Richards Jr. -- Section III Endemic and Epidemic Hospital Infections -- 30. Incidence and Nature of Endemic and Epidemic Healthcare-Associated Infections / William R. Jarvis -- 31. Urinary Tract Infections / Carol E. Chenoweth -- 32. Hospital-Acquired and Ventilator-Associated Pneumonia / Henri Balaguera -- 33. Nosocomial Tuberculosis / Faiz Ahmad Khan -- 34. Infectious Gastroenteritis / Benjamin A. Lopman -- 35. Central Nervous System Infections / W. Michael Scheld -- 36. Surgical Site Infections / Keith S. Kaye -- 37. Infections of Burn Wounds / Basil A. Pruitt, Jr. -- 38. Infections due to Infusion Therapy / Leonard A. Mermel -- 39. Infections of Implantable Cardiac and Vascular Devices / Raymond Y. Chinn -- 40. Infections in Skeletal Prosthesis and Allografts / Daniel P. Lew -- 41. The Importance of Infection Control in Controlling Antimicrobial-Resistant Organisms / Barry M. Farr -- 42. Healthcare-Associated Respiratory Viral Infections / Janice Lo -- 43. Preventing Transmission of Bloodborne Pathogens in the Healthcare Setting / David K. Henderson -- 44. Healthcare-Associated Fungal Infections / Benjamin J. Park -- 45. Healthcare-Associated Infections in Transplant Recipients / Kent Sepkowitz -- 46. Miscellaneous Procedure-Related Infections / Robert A. Weinstein -- 47. Public Reporting of Healthcare-Associated Infection Rates / Michael P. Stevens -- 48. Patient Safety / Moi Lin Ling.
- 2007 Ovideditor, William R. Jarvis.Epidemiology of healthcare-associated infections -- The healthcare epidemiologist -- Hand hygiene -- Personnel health services -- The development of infection surveillance and control programs -- Surveillance of healthcare-associated infections -- Investigating endemic and epidemic healthcare-associated infections -- Epidemiological methods for investigating infections in the healthcare setting -- Use of computerized systems in healthcare epidemiology -- The role of the laboratory in control of healthcare-associated infections -- The practice of epidemiology in community hospitals -- The role of professional and regulatory organizations in infection control -- Antimicrobial stewardship: programmatic efforts to optimize antimicrobial use -- Multiply drug-resistant pathogens: epidemiology and control -- Molecular biology of resistance -- Economic evaluation of healthcare-associated infections and infection control interventions -- Legal aspects of healthcare-associated infections -- Infection control: a global view -- The inanimate environment -- Sterilization and disinfection -- Foodborne disease prevention in healthcare facilities -- Clinical laboratory-acquired infections -- Dialysis-associated complications and their control -- The intensive care unit: part A. HAI epidemiology, risk factors, surveillance, engineering and administrative infection control practices, and impact -- The intensive care unit: part B. antibiotic resistance and prevention of CVC-BSIs, catheter-associated urinary tract infections and C. difficile -- The newborn nursery and the neonatal intensive care unit -- The operating room -- Ambulatory care setting -- Infections in long-term care facilities -- Incidence and nature of endemic and epidemic healthcare-associated infections -- Urinary tract infections -- Hospital-acquired pneumonia -- Tuberculosis -- Infectious gastroenteritis -- Central nervous system infections -- Surgical site infections -- Infections of burn wounds -- Infections due to infusion therapy -- Infections of implantable cardiac and vascular devices -- Infections in skeletal prostheses -- The importance of infection control in controlling antimicrobial-resistant pathogens -- Healthcare-associated respiratory viral infections -- Blood borne pathogen prevention -- Healthcare-associated fungal infections -- Infection in transplant recipients -- Miscellaneous procedure-related infections -- Public reporting of healthcare-associated infection rates -- Patient safety.Also available: Print – 2007
- 2006 CRCnetBASEedited by James R. Swearengen.
- 2014 CRCnetBASEedited by S. M. Abu Sayem.Front Cover; About the Editor; Contents; Acknowledgment and How to Cite; List of Contributors; Introduction; Chapter 1: Potential Novel Therapeutic Strategies in Cystic Fibrosis: Antimicrobial and Anti-Biofilm Activity of Natural and Designed [alpha]-Helical Peptides Against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia; Chapter 2: Dispersal of Biofilms by Secreted, Matrix Degrading, Bacterial DNase. 1. Potential novel therapeutic strategies in cystic fibrosis : antimicrobial and anti-biofilm activity of natural and designed A-helical peptides against staphylococcus aureus, pseudomonas aeruginosa, and stenotrophomonas maltophilia / Arianna Pompilio, Valentina Crocetta, Marco Scocchi, Stefano Pomponio, Valentina Di Vincenzo, Mario Mardirossian, Giovanni Gherardi, Ersilia Fiscarelli, Giordano Dicuonzo, Renato Gennaro, and Giovanni Di Bonaventura -- 2. Dispersal of biofilms by Secreted, Matrix Degrading, Bacterial DNase / Reindert Nijland, Michael J. Hall, and J. Grant Burgess -- 3. The RNA processing enzyme polynucleotide phosphorylase negatively controls biofilm formation by repressing poly-n-acetylglucosamine (PNAG) production in escherichia coli C / Thomas Carzaniga, Davide Antoniani, Gianni Deh, ̣Federica Briani, and Paolo Landini -- 4. Comparative proteomic analysis of streptococcus suis biofilms and planktonic cells that identified biofilm infection-related immunogenic proteins / Yang Wang, Li Yi, Zongfu Wu, Jing Shao, Guangjin Liu, Hongjie Fan, Wei Zhang, and Chengping Lu -- 5. Anti-biofilm activity of an exopolysaccharide from a sponge-associated strain of bacillus licheniformis / S.M. Abu Sayem, Emiliano Manzo, Letizia Ciavatta, Annabella Tramice, Angela Cordone, Anna Zanfardino, Maurilio De Felice, and Mario Varcamonti -- 6. Osteopontin reduces biofilm formation in a multi-species model of dental biofilm / Sebastian Schlafer, Merete K. Raarup, Peter L. Wejse, Bente Nyvad, Brigitte M. Std̃ler, Duncan S. Sutherland, Henrik Birkedal, and Rikke L. Meyer -- 7. Impairment of the bacterial biofilm stability by triclosan / Helen V. Lubarsky, Sabine U. Gerbersdorf, Cďric Hubas, Sebastian Behrens, Francesco Ricciardi, and David M. Paterson -- 8. Antimicrobial pressure of ciprofloxacin and gentamicin on biofilm development by an endoscope-isolated pseudomonas aeruginosa / Idalina Machado, Joana Graȧ, Hľder Lopes, Susana Lopes, and Maria O. Pereira -- 9. Inhibition of staphylococcus epidermidis biofilm formation by traditional Thai herbal recipes used for wound treatment / S. Chusri, K. Sompetch, S. Mukdee, S. Jansrisewangwong, T. Srichai, K. Maneenoon, S. Limsuwan, and S.P. Voravuthikunchai -- 10. In vitro assessment of shiitake mushroom (lentinula edodes) extract for its antigingivitis activity / Lena Ciric, Anna Tymon, Egija Zaura, Peter Lingstrm̲, Monica Stauder, Adele Papetti, Caterina Signoretto, Jonathan Pratten, Michael Wilson, and David Spratt -- 11. Antimicrobial, antimycobacterial and antibiofilm properties of couroupita guianensis aubl. fruit extract / Naif Abdullah Al-Dhabi, Chandrasekar Balachandran, Michael Karunai Raj, Veeramuthu Duraipandiyan, Chinnasamy Muthukumar, Savarimuthu Ignacimuthu, Inshad Ali Khan, and Vikrant Singh Rajput -- 12. Fur is a repressor of biofilm formation in yersinia pestis / Fengjun Sun, He Gao, Yiquan Zhang, Li Wang, Nan Fang, Yafang Tan, Zhaobiao Guo, Peiyuan Xia, Dongsheng Zhou, and Ruifu Yang -- 13. Hsp90 governs dispersion and drug resistance of fungal biofilms / Nicole Robbins, Priya Uppuluri, Jeniel Nett, Ranjith Rajendran, Gordon Ramage, Jose L. Lopez-Ribot, David Andes, and Leah E. Cowen -- 14. Candida biofilms and the host : models and new concepts for eradication / Hľn̈e Tournu and Patrick Van Dijck -- 15. Innovative strategies to overcome biofilm resistance / Aleksandra Taraszkiewicz, Grzegorz Fila, Mariusz Grinholc, and Joanna Nakonieczna.
- 2015 SpringerGianfranco Donelli, editor.The aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.Also available: Print – 2015
- 2015 SpringerGianfranco Donelli, editor.The aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.Also available: Print – 2015
- 2006 CRCnetBASEedited by John L. Pace, Mark E. Rupp, and Roger G. Finch.Microbial biofilms / Xiuping Jiang and John L. Pace -- Economic impact of biofilms on treatment costs / John G. Thomas, Isaiah Litton, and Harald Rinde -- Biofilm-related indwelling medical device infections / Matthew K. Schinabeck and Mahmoud A. Ghannoum -- Medical device composition and biological secretion influences on biofilm formation / Sean P. Gorman and David S. Jones -- Role of biofilms in infections caused by Escherichia coli / Grégory Jubelin, Corinne Dorel, and Philippe Lejeune -- Staphylococcus aureus biofilms / Julie M. Higashi and Paul M. Sullam -- Coagulase-negative staphylococci / Dietrich Mach ... [et al.] -- Pseudomonas aeruginosa biofilm infections in cystic fibrosis / Andrea Smiley and Daniel J. Hassett -- Candida / Stephen Hawser and Khalid Islam -- Current perspectives on the regulation of the ica operon and biofilm formation in Staphylococcus epidermidis / Paul D. Fey and Luke D. Handke -- Cell-to-cell communication in bacteria / Kenneth D. Tucker and Luciano Passador -- Persisters: specialized cells responsible for biofilm tolerance to antimicrobial agents / Kim Lewis ... [et al.] -- Minimal biofilm eradication concentration (MBEC) assay: susceptibility testing for biofilms / Howard Ceri ... [et al.] -- Environmental cues regulate virulence and biofilm formation / John L. Pace and Steven M. Frey -- In vivo models for the study of biomaterial-associated infection by biofilm-forming staphylococci / Luke D. Handke and Mark E. Rupp -- Host response to biofilms / Susan Meier-Davis -- Pharmacodynamics and the treatment of IMD-related infections / Roger Finch and Sarah Gander -- Protein synthesis inhibitors, fluoroquinolones, and rifampin for biofilm infections / Steven L. Barriere -- [beta][beta]-lactams for the treatment of biofilm-associated infections / Ingrid L. Dodge, Karen Joy Shaw, and Karen Bush -- Glycopeptide antibacterials and the treatment of biofilm-related infections / John L. Pace, Roasaire Verna, and Jan Verhoef -- Antibiotic resistance in biofilms / Nafsika H. Georgopapadakou -- Treatment protocols for infections of vascular catheters / Russell E. Lewis and Issam I Raad -- Treatment protocols for bacterial endocarditis and infection of electrophysiologic cardiac devices / Martin E. Stryjewski and G. Ralph Corey -- Treatment protocol of infections of orthopedic devices / Vera Antonios, Elie Berbari, and Douglas Osmon.
- 2009 Springeredited by I.W. Fong and Kenneth Alibek.Anthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
- 2005- Springerseries eds. Axel Schmidt, Stefan H.E. Kaufmann, Manfred H. Wolff.Infectious diseases remain a substantial drain on human well-being and economies despite the availability of modern drugs. New pathogens emerge and known pathogens change their geographical distribution and their susceptibility to the available drugs. An understanding of the structure and function of infectious disease pathogens is a major scientific challenge with important potential applications. This monograph series provides up-to-date information on the latest developments in infectious disease research. The multi-authored volumes cover basic biology and biochemistry of pathogens as well as applied medical aspects and implications for public health and policy.-- Excerpted from publisher notes.
- 2012 SpringerArmen A. Galoyan.The Cytokine System -- The Discovery of the Brain Immunomodulators -- Brain Neuroendocrine Immune System: Neurosecretion of Interleukins and New Cytokines Produced by NSO and NPV of Hypothalamus -- Antibacterial and Antiviral Activity of PRP-1 (Galarmin) and Some Immunological Mechanisms of its Action -- Treatment and Prophylaxis of Anthrax by Galarmin: Receptor Tyrosine Kinases is a Target of Galarmin -- Prophylaxis and Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection with Proline-Rich Polypeptides Galarmin and Its Structural Analogues in an Experimental Murine Model -- Treatment of Clostridium Perfringens-induced Gas Gangrene by New Cytokines of Brain -- Hypothalamic, Proline-Rich Polypeptide (Galarmin) has Protective and Immunogenic Activity on Experimental Mycobacterium Tuberculosis Infection -- Brain-Bone Marrow Neurohumoral Axis: Galarmin Controls Differentiation, Proliferation and Mobilization of Bone Marrow Progenitor cells -- Antioxidant-Antiradical and Electron Donating Function of Galarmin and Gx-NH2 -- Discussion -- Summary.
- 2006 Springeredited by B.G.J. Knols and C. Louis.Executive summary -- Report of the working-group meeting / Christos Louis and Bart G.J. Knols -- Review of previous applications of genetics to vector control / Chris F. Curtis -- Genomics and expected benefits for vector entomology / Christos Louis -- Genetic approaches for malaria control / Marcelo Jacobs-Lorena -- Current thoughts about the integration of field and laboratory sciences in genetic control of disease vectors / Thomas W. Scott -- Genetic approaches in Aedes aegypti for control of dengue: an overview / Kenneth Olson .... [et al.] -- Malaria and dengue vector biology and control in West and Central Africa / Didier Fontenille and Pierre Carnevale -- Malaria and dengue vector biology and control in Southern and Eastern Africa / Maureen Coetzee -- Malaria and dengue vector biology and control in Southeast Asia / Pattamaporn Kittayapong -- Malaria and dengue vector biology and control in Latin America / Mario H. Rodriguez -- Transition from the laboratory to the field and effective interplay / Christos Louis -- Evaluation of drive mechanisms (including transgenes and drivers) in different environmental conditions and genetic backgrounds / Anthony A. James ... [et al.] -- Tools for monitoring the genetic structure and stability of mosquito populations / Gregory C. Lanzaro, Sergey Nuzhdin and Frederic Tripet -- What are relevant assays for refractoriness / George K. Christophides ... [et al.] -- Fitness studies: developing a consensus methodology / Thomas W. Scott ... [et al.] -- Mosquito mating behaviour / Willem Takken ... [et al.] -- Pathogen evolution issues in genetically modified mosquito vector strategies / Mario H. Rodriquez -- Models to investigate some issues regarding the feasibility of driving refractoriness genes into mosquito vector populations / Chris F. Curtis -- Identification and characterization of field sites for genetic control of disease vectors / Bart G.J. Knols and Hervé Bossin -- Application of genetically modified mosquitoes in national vector control programmes: thoughts on integrated control / Abraham Mnzava ... [et al.] -- Entomological correlates of epidemiological impacts: how do we know it is working? / Andrew Githeko -- Ethical, legal and social issues in the use of genetically modified vectors for disease control / Yeya T. Touré and Lucien Manga.
- 2014 ScienceDirectJane E. Sykes.Basic principles in the diagnosis and management of small animal infection -- Laboratory diagnosis of canine and feline infectious diseases -- Isolation in cell culture -- Immunoassays -- Isolation and identification of aerobic and anaerobic bacteria -- Isolation and identification of fungi -- Nucleic acid detection assays -- Antiinfective therapy -- Principles of antiinfective therapy -- Antiviral and immunomodulatory drugs -- Antibacterial drugs -- Antifungal drugs -- Antiprotozoal drugs -- Basic principles for infection control -- Infection control programs for dogs and cats -- Immunization -- Major infectious diseases and their etiologic agents -- Viral diseases -- Rabies -- Canine parvovirus infections and other viral enteritides -- Canine distemper virus infection -- Canine herpesvirus infection -- Canine viral respiratory infections -- Infectious canine hepatitis -- Feline panleukopenia virus infection and other viral enteritides -- Feline coronavirus infection -- Feline immunodeficiency virus infection -- Feline leukemia virus infection -- Feline respiratory viral infections -- Feline poxvirus infections -- Pseudorabies -- Viral papillomatosis -- Vector-borne and other viral encephalitides -- Bacterial diseases -- Ehrlichiosis -- Anaplasmosis -- Rocky mountain spotted fever -- Salmon poisoning disease -- Coxiellosis and q fever -- Chlamydial infections -- Streptococcal and enterococcal infections -- Staphylococcus infections -- Gram-negative bacterial infections -- Anaerobic bacterial infections -- Bordetellosis -- Cell wall-deficient bacterial infections -- Mycoplasma infections -- Hemoplasma infections -- Actinomycosis -- Nocardiosis -- Mycobacterial infections -- Salmonellosis -- Enteric Escherichia coli infections -- Campylobacteriosis -- Enteric clostridial infections -- Gastric Helicobacter-like infections -- Leptospirosis -- Lyme borreliosis -- Bartonellosis -- Canine brucellosis -- Tetanus and botulism -- Yersinia pestis (plague) and other yersinioses -- Tularemia -- Bite and scratch wound infections -- Fungal and algal diseases -- Dermatophytosis -- Malassezia infections -- Blastomycosis -- Histoplasmosis -- Cryptococcosis -- Coccidioidomycosis -- Sporotrichosis -- Aspergillosis -- Rhinosporidiosis -- Candidiasis -- Miscellaneous fungal diseases -- Pythiosis, lagenidiosis, and zygomycosis -- Protothecosis -- Pneumocystosis -- Protozoal diseases -- Toxoplasmosis -- Neosporosis -- Leishmaniosis -- Babesiosis -- Cytauxzoonosis -- Canine and feline hepatozoonosis -- Trypanosomiasis -- Giardiasis -- Trichomoniasis -- Cryptosporidiosis -- Isosporiasis -- Miscellaneous protozoal diseases -- Infections of selected organ systems -- Pyoderma, otitis externa, and otitis media -- Osteomyelitis, discospondylitis, and infectious arthritis -- Infections of the cardiovascular system -- Bacterial bronchopneumonia and pyothorax -- Intra-abdominal infections -- Bacterial infections of the genitourinary tract -- Bacterial meningitis -- Vaccination schedules for dogs and cats.
- 2013 SpringerI. W. Fong, editor."This new volume ... aims to address demands and challenges that various infections present to the world at large ('global challenges'), such as the HIV pandemic, continuous threat of spreading common multiresistant pathogenic bacteria, multidrug and extensive drug-resistant tuberculosis, and the influence we can expect on these epidemics with global climate change and international urbanization ... Chapters on these various topics authored by world-renowned experts on these areas provide state-of-the-art reviews on epidemiology, biology, clinical aspects, prevention, current approaches to control, and prevention such as new vaccines, and reassessment of past and present methods are discussed"--Preface.
- 2013 Kargervolume editor, Carolyn M. Black.Epidemiology and prevention and control programs for chlamydia / C.L. Satterwhite, J.M. Douglas, Jr. -- Chlamydia trachomatis pathogenicity and disease / D. Dean -- Chlamydia trachomatis genome structure / T.E. Putman, D.D. Rockey -- Chlamydia trachomatis : molecular testing methods / C.A. Gaydos -- Treatment of chlamydia trachomatis infections / M.R. Hammerschlag -- The Immunologic Response to Urogenital Infection / R.M. Johnson, W. Geisler -- Chlamydia vaccine development / J.U. Igietseme, C.M. Black -- Maternal and infant chlamydia trachomatis infections / I.G.I.J.G. Rours, M.R. Hammerschlag -- Chlamydia trachomatis infection among sexual minorities / D. Singh, J.M. Marrazzo -- Lymphogranuloma venereum : a concise outline of an emerging infection among men who have sex with men / H.J.C. de Vries, S. Morré.
- 2014 SpringerG. Balakrish Nair and Yoshifumi Takeda, editors.The most feared attribute of the human pathogen Vibrio cholerae is its ability to cause outbreaks that spread like wildfire, completely overwhelming public health systems and causing widespread suffering and death. This volume starts with a description of the contrasting patterns of outbreaks caused by the classical and El Tor biotypes of V. cholerae. Subsequent chapters examine cholera outbreaks in detail, including possible sources of infection and molecular epidemiology on three different continents, the emergence of new clones through the bactericidal selection process of lytic cholera phages, the circulation and transmission of clones of the pathogen during outbreaks, and novel approaches to modeling cholera outbreaks. A further contribution deals with the application of the genomic sciences to trace the spread of cholera epidemics and how this information can be used to control cholera outbreaks. The book closes with an analysis of the potential use of killed oral cholera vaccines to stop the spread of cholera outbreaks.
- 2015 SpringerRobert A. Norman, William Eng, editors.This clinical case book serves as a useful guide for dermatologists, internists, family practitioners, pediatricians, and anyone else charged with the care of infectious diseases of the skin of parasitic, fungal, bacterial, and viral origin. The case-based format distinguishes this work from a reference-style textbook, allowing readers to relate the presented cases to their own practice. Clinical Cases in Infections and Infestations of the Skin provides help and insight for clinicians in managing skin disease, with each chapter serving as a springboard for further pursuit and more extensive training. ℗ℓThe reader will find useful information and tools to help patients and will enable readers to add to their current clinical regimens by becoming familiar with healing systems beyond medical dermatology. The book will enable those new to the field to develop a literacy and competence in the management of infectious dermatology.℗ℓ For the more experienced learner, it will assist in finding new ways to sharpen diagnostic and treatment acumens.
- 2012 SpringerAsghar Aghamohammadi, Nima Rezaei, editors.Primary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying PIDs.This book aims to increase the clinical awareness and knowledge of practicing clinicians regarding the diagnosis and management of PIDs. In order to achieve this goal, about 90 cases drawn from real life are presented, along with approximately 300 related questions. The selected case reports are the result of the invaluable cooperation of more than 40 scientists in the field of immunodeficiency. They focus both on the presenting features of patients with PIDs and on the required further investigation and management. Although the case scenarios relate to real histories, some modifications have been made for educational purposes. Each of the numbered cases is followed by the questions, their answers, and additional discussion. Each question focuses on a particular aspect of the PID under consideration, and the topics covered include clinical diagnosis, laboratory findings, molecular mechanisms, and therapy.This practical, case-oriented book will be an invaluable source of guidance on the diagnosis and treatment of patients with PIDs and will be relevant for those working in a variety of specialties and subspecialties.
- 2015 Cambridgeedited by David Schlossberg, MD, FACP, Professor of Medicine, Temple University School of Medicine, Adjunct Professor of Medicine, University of Pennsylvania School of Medicine, and Director, Tuberculosis Control Program, Philadelphia Department of Public Health, Philadelphia, PA.Part I. Clinical syndromes: general -- Part II. Clinical syndromes: head and neck -- Part III. Clinical syndromes: eye -- Part IV. Clinical syndromes: skin and lymph nodes -- Part V. Clinical syndromes: respiratory tract -- Part VI. Clinical syndromes: heart and blood vessels -- Part VII. Clinical syndromes: gastrointestinal tract, liver, and abdomen -- Part VIII. Clinical syndromes: genitourinary tract -- Part IX. Clinical syndromes: musculoskeletal system -- Part X. Clinical syndromes: neurologic system -- Part XI. The susceptible host -- Part XII. HIV -- Part XIIII. Nosocomial infection -- Part XIV. Infections related to surgery and trauma -- Part XV. Prevention of infection -- Part XVI. Travel and recreation -- Part XVII. Bioterrorism -- Part XVIII. Specific organisms: bacteria -- Part XIX. Specific organisms: spirochetes -- Part XX. Specific organisms: Mycoplasma and Chlamydia -- Part XXI. Specific organisms: Rickettsia, Ehrlichia, and Anaplasma -- Part XXII. Specific organisms: fungi -- Part XXIIII. Specific organisms: viruses -- Part XXIV. Specific organisms: parasites -- Part XXX. Antimicrobial therapy: general considerations -- Index.
- 2008 ClinicalKeyW. John Spicer ; illustrated by Peter Lamb and Robert Britton.Microbes -- Microbial attack and control by intrinsic defences -- Specific pathogens. Bacteria ; Fungi ; Arthropods ; Parasites ; Viruses -- Microbial attack succeeds : clinical infection -- Microbe control by extrinsic defences.
- 2012 SpringerRobert W. Finberg, Roy Guharoy.
- 2013 Future Mededitors, Glenn S. Tillotson, Karl Weiss.Clostridium difficile : new challenges for an old foe / Glenn S. Tillotson & Karl Weiss -- Clostridium difficile infection : a global threat / Nuttanun Suramaethakul & Teena Chopra -- Pathogenicity mechanisms of Clostridium difficile / Mark M. Collery, Revathi Govind, Nigel P. Minton & Sarah A. Kuehne -- Immunology and Clostridium difficile / Ciarán P. Kelly & Saurabh Sethi -- The microbiome and Clostridium difficile infection / Charles Y. Chiu & Dylan R. Pillai -- Economic burden of Clostridium difficile infection / Samuel L. Aitken, Dhara N. Shah & Kevin W. Garey -- Laboratory diagnosis of Clostridium difficile infection / Peter H. Gilligan -- Conventional therapeutics for Clostridium difficile infection / Jessica Martin & Mark Wilcox -- Infection control issues in Clostridium difficile / Scott Curry -- Future and alternative approaches to managing Clostridium difficile infection / Glenn S. Tillotson & Karl Weiss -- Recent advances with Clostridium difficile / Joni Tillotson & Glenn S. Tillotson -- Index.
- 2014 SpringerJuan Carlos García-Moncó, editor."This clinically oriented book covers selected infections of the central nervous system which are of considerable current interest. Aspects that are less well documented, such as spinal cord infections, central nervous system infections in patients with cancer, tropical infections, healthcare-associated ventriculitis or meningitis, and immunological problems in the international traveler are also discussed, as these are all problems relevant to daily practice."--Publisher's website.
- 2009 SpringerRainer Sundmacher.
- 2006 SpringerDavid R. Ramsdale.
- 2009 SpringerRonald Eccles, Olaf Weber, editors.
- 2007 Springeredited by N. Suttorp, T. Welte and R. Marre.Diagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections - epidemiology, immunity, cell biology, virulence factors -- Legionnaires' disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections: adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections: adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
- 2008 SpringerOlaf Weber, Ulrike Protzer, editors.
- 2006 Springeredited by Cecelia Hutto.
- 2011 SpringerGabriele Halwachs-Baumann, editor.Congenital cytomegalovirus (CMV) infection is the most common intrauterine transmitted viral infection, with a tremendous impact on fetuses and newborns. In this book the history of this disease, its pathophysiological background, epidemiology and symptoms, as well as diagnostic and therapeutic strategies, will be discussed. Since economic aspects are gaining more and more importance in health politics, one chapter is dedicated to this issue in the context of congenital CMV infection. The content is based on the latest scientific findings and written in an understandable manner, allowing persons not working in the field of congenital CMV to also profit from it. Thus, this book is of interest for medical doctors, nurses, midwives, economists, but also for men and women who want to inform themselves about this topic.
- 2012 SpringerJulio Aliberti, editor.
- 2005 Springeredited by A. Schmidt, M.H. Wolff, and O. Weber.
- 2014 SpringerSimone M. Cacciò, Giovanni Widmer, editors.This new volume on Cryptosporidium and Cryptosporidiosis discusses all relevant aspects of the biology, molecular biology, host-parasite interaction, epidemiology as well as diagnosis and treatment of these widespread parasites. It represents a useful guide for physicians, microbiologists, veterinarians and water professionals seeking advanced knowledge and guidance about these important parasitic pathogens. A section on practical lab procedures discusses step-by-step guidelines for sample preparation and lab procedures. The new book may further serve as a reference work for graduate students in medical and veterinary microbiology.
- 2008 CRCnetBASE[edited by] Ronald Fayer, Lihua Xiao.General biology / Ronald Fayer -- Genomics / Jessica C. Kissinger -- Biochemistry / Guan Zhu -- Epidemiology / Gordon Nichols -- Molecular epidemiology / Lihua Xiao and Una M. Ryan -- Diagnostics / Huw Smith -- Immune responses / Vincent McDonald -- Clinical disease and pathology / Cirle Alcantara Warren and -- Richard l. Guerrant -- Prophylaxis and chemotherapy / Heather D. Stockdale, Jennifer A. Spencer, and Byron L. Blagburn -- Foodborne transmission / Ynes R. Ortega and Vitaliano A. Cama -- Waterborne: drinking water / Jennifer L. Clancy and Thomas M. Hargy -- Waterborne: recreational water / Michael Beach -- Waste management / Dwight D. Bowman -- Fish, amphibians and reptiles / Thaddeus Graczyk -- Birds / Una Ryan and Lihua Xiao -- Zoo and wild mammals / Olga Matos -- Companion animals / Mónica Santín and James M. Trout -- Livestock / Mónica Santín and James M. Trout -- Animal models / Saul Tzipori and Giovanni Widmer -- In vitro cultivation / Michael J. Arrowood.
- 2011 Future Mededitor, Stefan H.E. Kaufmann.A concise guide to TB control / Stefan HE Kaufmann -- Unmet medical needs for diagnostics, drugs and vaccines / Syed Huq & Peter D.O. Davies -- TB diagnostics : current pipeline, new developments and unmet needs / Madhukar Pai, Samuel G. Schumacher, Hojoon Sohn & Claudia M. Denkinger -- Antituberculosis therapy and current global guidelines / Giovanni Battista Migliori, Giovanni Sotgiu, Rosella Centis, Malgorzata Grzemska, Dennis Falzon, Haileyesus Getahun & Mario C. Raviglione -- New therapeutics in development and future directions / Anna Upton & Zhenkun Ma -- New vaccines in development and future direction / Helen McShane & Rosalind Rowland.
- 2015 ScienceDirectedited by Andew Sails and Yi-Wei Tang.Chapter 1. Total laboratory automation in clinical bacteriology -- Chapter 2. MALDI-TOF mass spectrometry for microorganism identification -- Chapter 3. POC tests in microbial diagnostics: current status -- Chapter 4. Molecular diagnostics in the diagnosis of parasitic infection -- Chapter 5. Clinical applications of quantitative real-time PCR in virology -- Chapter 6. Low-density TaqMan® array cards for the detection of pathogens -- Chapter 7. Invasive fungal infections and approaches to their diagnosis -- Chapter 8. Technical and software advances in bacterial pathogen typing -- Chapter 9. Molecular strain typing and characterisation of toxigenic Clostridium difficile -- Chapter 10. Accurate whole-genome sequencing-based epidemiological surveillance of Mycobacterium Tuberculosis -- Chapter 11. Solid and suspension microarrays for microbial diagnostics -- Chapter 12. Gene amplification and sequencing for bacterial identification -- Chapter 13. Host-based diagnostics for detection and prognosis of infectious diseases -- Chapter 14. MALDI-TOF mass spectrometry in the clinical microbiology laboratory: beyond identification -- Chapter 15. Next-generation sequencing for pathogen detection and identification -- Chapter 16. Virology: the next generation from digital PCR to single virion genomics -- Chapter 17. Artificial nucleic acid probes and their applications in clinical microbiology -- Index.
- 2010 SpringerK. Tanaka, Y. Niki, A. Kokaze (Eds.).Features of enteric infections in Asia -- Molecular epidemiology of vibrio cholerae and campylobacters isolated in Asian countries -- Diarrheal diseases and probiotics -- Dengue and chikungunya virus infection in Southeast Asia: active governmental intervention in Republic of Singapore -- Current global situation of tuberculosis, with a focus on Japan -- Tuberculosis among the poor -- The status and trends of HIV/AIDS epidemics in Asia and the Pacific -- Disease characteristics and treatment of 2009 H1N1 influenza -- Drug-resistant respiratory pathogens in Japan.
- 2012 Springerby Marc E. Grossman, Lindy P. Fox, Carrie Kovarik, Misha Rosenbach.Subcutaneous and deep mycoses -- Hyalohyphomycosis -- Superficial mycoses -- Algae -- Mycobacteria -- Viruses -- Rickettsiae -- Crusted scabies -- Protozoa -- Helminth -- Spirochete -- Gram-Positive bacteria -- Gram-negative bacteria -- Viral related malignancies -- Clues to the diagnosis of skin lesions in the immunocompromised host -- Differential diagnoses.
- 2012 SpringerLiron Pantanowitz, Pam Michelow, Walid E. Khalbuss.Introduction -- Specimen Collection and Handling -- Host Reactions to Infection -- Microbiology -- Gynecological Infections -- Pulmonary Infections -- Gastrointestinal and Hepatobiliary Infections -- Urinary Tract Infections -- Central Nervous System Infections -- Hematologic Infections -- Breast, Skin, and Musculoskeletal Infections -- Head and Neck Infections -- Immunosuppressed Host -- Ancillary Investigations -- Mimics and Contaminants.
- 2009 WHO"Since the second edition of Dengue haemorrhagic fever: diagnosis, treatment, prevention and control was published by the World Health Organization (WHO) in 1997, the magnitude of the dengue problem has increased dramatically and has extended geographically to many previously unaffected areas. It was then, and remains today, the most important arthropod-borne viral disease of humans. Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA55.17 (adopted by the Fifty-fifth World Health Assembly in 2002) and at the regional level by resolution CE140.R17 of the Pan American Sanitary Conference (2007), resolution WPR/RC59.R6 of the WHO Regional Committee for the Western Pacific (2008) and resolution SEA/RC61/R5 of the WHO Regional Committee for South-East Asia (2008). This new edition has been produced to make widely available to health practitioners, laboratory personnel, those involved in vector control and other public health officials, a concise source of information of worldwide relevance on dengue. The guidelines provide updated practical information on the clinical management and delivery of clinical services; vector management and delivery of vector control services; laboratory diagnosis and diagnostic tests; and surveillance, emergency preparedness and response. Looking ahead, some indications of new and promising avenues of research are also described. Additional and more detailed specific guidance on the various specialist areas related to dengue are available from other sources in WHO and elsewhere, some of which are cited in the references. The contributions of, and review by, many experts both within and outside WHO have facilitated the preparation of this publication through consultative and peer review processes. All contributors are gratefully acknowledged, a list of whom appears under "Acknowledgements". These guidelines are the result of collaboration between the WHO Department of Control Neglected Tropical Diseases, the WHO Department of Epidemic and Pandemic Alert and Response, and the Special Programme for Research and Training in Tropical Diseases. This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity, since many aspects of the prevention and control of dengue are currently being investigated in a variety of studies. The guidelines contain the most up-to-date information at the time of writing. However, the results of studies are being published regularly and should be taken into account. To address this challenge, the guide is also available on the Internet and will be updated regularly by WHO." - p. v.Also available: Print – 2009
- 2014 Springer Protocolsedited by Radhakrishnan Padmanabhan, Subhash G. Vasudevan.Dengue Virus Growth, Purification and Fluorescent Labeling -- Isolation and Titration of Dengue Viruses by the Mosquito Inoculation Technique -- Measuring Antibody Neutralization of Dengue Virus (DENV) Using a Flow Cytometry-Based Technique -- Dengue Virus Purification and Sample Preparation for Cryo-Electron Microscopy -- Development of a Multiplex Bead-Based Assay to Monitor Dengue Virus Seroconversion -- Pseudo-Infectious Reporter Virus Particles for Measuring Antibody-Mediated Neutralization and Enhancement of Dengue Virus Infection -- Cell-Based Flavivirus Infection (CFI) Assay for the Evaluation of Dengue Antiviral Candidates Using High Content Imaging -- Development and Application of Dengue Virus Reverse Genetic Systems -- DENV4 Renilla Luciferase Reporter Replicons -- Targeted Mutagenesis of Dengue Virus Type 2 replicon RNA by Yeast in vivo Recombination -- Identification of Dengue-Specific Human Antibody Fragments Using Phage Display -- Next Generation Whole Genome Sequencing of Dengue Virus -- MPGAfold in Dengue Secondary Structure Prediction -- Insights into Secondary and Tertiary Interactions of Dengue Virus RNA by SHAPE -- Use of Small Angle X-Ray Scattering to Investigate the Structure and Function of Dengue Virus NS3 and NS5 -- Identification of Dengue RNA Binding Proteins Using RNA Chromatography and Quantitative Mass Spectrometry -- Analysis of Affinity of Dengue Virus Protein Interaction Using BIAcore -- Functional Genomics Approach for the Identification of Human Host Factors Supporting Dengue Viral Propagation -- Investigating Dengue Virus Non-Structural Protein 5 (NS5) Nuclear Import -- Small Molecule Inhibitor Discovery for Dengue Virus Protease Using High Throughput Screening -- Construction of Dengue Virus Protease Expression Plasmid and in vitro Protease Assay for Screening Antiviral Inhibitors -- Construction of Plasmid, Bacterial Expression, Purification, and Assay of Dengue Virus Type 2 NS5 Methyltransferase -- Animal Models in Dengue -- Evaluation of Dengue Antiviral Candidates In Vivo in Mouse Model.
- 2014 Future Mededitors, James Whitehorn, Jeremy Farrar.Dengue : transmission, diagnosis and surveillance / James Whitehorn & Jeremy Farrar -- Biomarkers for dengue : prospects and challenges / Sophie Yacoub, Annette Fox, Nguyen Van Kinh, Gavin Screaton & Heiman Wertheim -- Dengue diagnosis : commercially available kits and laboratory support / Monique da Rocha Queiroz Lima, Rita Maria Ribeiro Nogueira & Flávia Barreto dos Santos -- Lessons learned from dengue : focus on Taiwan / Tzong-Shiann Ho, Chiou-Feng Lin, Ching-Chuan Liu, Trai-Ming Yeh, Robert Anderson & Yee-Shin Lin -- Dengue and international travel / Silvia Odolini, Alberto Matteelli & Francesco Castelli -- Intraepidemic increases in dengue disease severity : applying lessons on surveillance & transmission / Scott B. Halstead -- Prospects for controlling dengue spread : vaccines and vector control / Monica A. McArthur, Marcelo B. Sztein & Robert Edelman -- Ask the experts : surveillance of global dengue distribution / Jane Messina, Oliver Brady, Simon Hay, Jeremy Farrar & James Whitehorn -- Multiple choice questions : answers.
- 2015 SpringerDuane R. Hospenthal, Michael G. Rinaldi, editors.Part One Approach to Patients -- Chapter 1 Approach to Patients with Suspected Fungal Infections -- Part Two Laboratory and Radiological Diagnosis -- Chapter 2 Basic Mycology -- Chapter 3 Diagnostic Molecular Biology -- Chapter 4 Diagnostic Histopathology -- Chapter 5 Diagnostic Immunology -- Chapter 6 Diagnostic Radiology -- Part Three Antifungal Agents -- Chapter 7 Antifungal Agents -- Part Four Mycoses -- Chapter 8 Candidiasis -- Chapter 9 Infection Due to non-Candidal Yeasts -- Chapter 10 Aspergillosis -- Chapter 11 Hyalohyphomycosis -- Infection Due to Hyaline Moulds -- Chapter 12 Phaeohyphomycosis -- Infection Due to Dark (Dematiaceous) Moulds -- Chapter 13 Mucormycosis (Zygomycosis) -- Chapter 14 Pneumocystosis -- Chapter 15 Cryptococcosis -- Chapter 16 Blastomycosis -- Chapter 17 Coccidioidomycosis -- Chapter 18 Histoplasmosis -- Chapter 19 Paracoccidioidomycosis -- Chapter 20 Sporotrichosis -- Chapter 21 Dermatophytosis (Tinea) and Other Superficial Fungal Infections -- Chapter 22 Fungal Infections of Implantation (Chromoblastomycosis, Mycetoma, Entomophthoramycosis and Lacaziosis) -- Part Five Instructive Cases. Instructive Cases -- Instructive Cases Discussion.
- 2007 Springeredited by Duane R. Hospenthal, Micheal G. Rinaldi.Part I. Approach to patients. Approach to patients with suspected fungal infections / Clinton K. Murray and Duane R. Hospenthal -- Part II. Laboratory and radiological diagnosis. Basic mycology / Deanna A. Sutton -- Diagnostic histopathology / Michael B. Smith and Michael R. McGinnis -- Diagnostic immunology / Samit S. Desai and Brian Wong -- Diagnostic radiology / Maria Angela C. Hospenthal and Constanza J. Gutierrez -- Part III. Antifungal agents. Antifungal agents / Russel E. Lewis and Annette W. Fothergill -- Part IV. Mycoses. Cadidiasis / Jack D. Sobel -- Infection due to non-candidal yeasts /Jose A. Vazquez -- Aspergillosis / Helen W. Boucher and Thomas F. Patterson -- Hyalophomycosis infection due to hyaline moulds / Rhonda V. Fleming and Elias J. Anaissie -- Phaeohyphomycosis infection due to dark (dematiaceous) moulds / Sanjay G. Revankar -- Zygomycosis (mucormycosis) / Charalampos Antachopoulos, Juan C. Gea-Banacloche, and Thomas J. Walsh -- Pneumocystosis / Francis Gigliotti and Terry W. Wright -- Cryptococcosis / Mathee Chayakulkeeree and John R. Perfect -- Blastomycosis / Stanley W. Champan and Donna C. Sullivan -- Coccidioidomycosis / Royce H. Johnson and Chehla Baqi -- Histoplasmosis / L. Joseph Wheat and Nicholas G. Conger -- Paraccocidiodoycosis / Angela Restrepo, Angela M. Tobón, and Carlos A. Agudelo -- Sporotrichosis / Carol A. Kauffman -- Dermatophytosis (tinea) and other superficial fungal infections / Aditya K. Gupta and Elizabeth A. Cooper -- Subcutaneous fungal infections (chromoblastomycossi, mycetoma, and lobomycosis) / Michael B. Smith and Michael R. McGinnis
- 2012 Springer Protocolsedited by Colin R. MacKenzie and Birgit Henrich.Overview of molecular biological methods for the detection of pathogens causing sexually transmitted infections / Fernando Vazquez [and others] -- Guidelines for the qualitative detection of viral genomes in dried blood spots / Davide Gibellini, Elisa De Crignis, and Maria Carla Re -- Guidelines for the quantification of HIV and HCV in small volume whole blood samples / Tony Bruns and Katrin Steinmetzer -- Guidelines for high-resolution genotyping of Chlamydia trachomatis using multilocus sequence analysis / Linus Christerson and Bjorn Herrmann -- Guidelines for the use of molecular tests for the detection and genotyping of human papilloma virus from clinical specimens / Sin Hang Lee -- Molecular diagnosis of sexually transmitted genital ulcer disease / Cheng-Yen Chen and Ronald C. Ballard -- Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients / R.B. Takkenberg, S. Menting, and M.G.H.M. Beld -- Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region v of the 23s rRNA gene / Jørgen Skov Jensen -- Protocols for detection and typing of Treponema pallidum using PCR methods / S.M. Bruisten -- Extraction of DNA from dried blood in the diagnosis of congenital CMV infection / Jutte J.C. de Vries [and others] -- Protocol for the use of PCR-denaturing gradient gel electrophoresis and quantitative PCR to determine vaginal microflora constitution and pathogens in bacterial vaginosis / Beatrice Vitali, Elena Biagi, and Patrizia Brigidi -- Protocol for the use of a bead array for the multiple detection of genotype of Chlamydia trachomatis / Chung-Te Huang and Shu-Ying Li -- Protocol for the detection and genotyping of human papillomaviruses using a liquid bead microarray assay / Stephen Cherne, Viorica Popov, and Qinghua Feng -- Protocol for the use of enzyme-linked hybridization assays for genital ulcer disease / Seweryn Bialasiewicz [and others] -- Protocol for the rapid detection of the urogential tract mollicutes and chlamydia with concomitant LGV-(sub)typing / Nadine Mobius [and others] -- Protocol for the use of self-reporting duplex mutation primers to detect PCR products in the diagnosis of HBV / Qian-Feng Xia -- Protocol for the use of a rapid real-time PCR method for the detection of HIV-1 proviral DNA using double-stranded primer / Chou-Pong Pau, Susan K. Wells, and Timothy C. Granade -- Protocol for the use of light upon extension real-time PCR for the determination of viral load in HBV infection / Guimin Li, Wangfeng Li, and Lixia Liu -- Protocol for the use of a silica nanoparticle-enhanced microcantilever sensor-based method to detect HBV at femtomolar concentrations / Sang-Myung Lee [and others] -- Protocol for the detection of Treponema pallidum in paraffin-embedded specimens / Cheng-Yen Chen and Allan Pillay -- Guidelines for the use of molecular biological methods to detect sexually transmitted pathogens in cases of suspected sexual abuse in children / Margaret R. Hammerschlag and Charlotte A. Gaydos -- Protocol for the molecular detection of antibiotic resistance mechanisms in Neisseria gonorrhoeae / Namraj Goire [and others] -- Protocol for a facile multiplex PCR for multi-antimicrobial resistance and gonococcus detection / Ratana Lawung, Rungrot Cherdtrakulkiat, and Virapong Prachayasittikul -- Protocol for gene expression profiling using DNA microarrays in Neisseria gonorrhoeae / Lydgia A. Jackson and David W. Dyer -- Protocol for analyzing human leukocyte antigen variants and sexually transmitted infections : from genotyping to immunoassays / Jianming Tang and Anju Bansal -- Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry / Kathrin Schonberg, Maryam Hejazi, and Markus Uhrberg -- Protocol for a mammalian cell-based assay for monitoring the HIV-1 protease activity / Chitra Rajakuberan, Brett J. Hilton, and Roland Wolkowicz -- Self-collection of specimens for nucleic acid-based diagnosis of pharyngeal, cervicovaginal, urethral, and rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections / Vivian Levy, Craig S. Blackmore, and Jeffrey D. Klausner -- Sexually transmitted diseases : reflections on metaphors and ethics / Gisela Badura-Lotter.
- 2016 SpringerPu-Xuan Lu, Bo-Ping Zhou, editors.This book introduces the diagnosis of Emerging Infectious Diseases (EIDs), including newly emerging infectious diseases and also infectious diseases that show resistance to present treatments. Radiographic examinations are of great value in EIDs diagnosis, differential diagnosis, treatment efficacy assessment and prognosis evaluation. This book covers severe acute respiratory syndrome (SARS), human avian influenza (H5N1, H7N9), influenza A (H1N1), hand-foot-mouth disease, acquired immune deficiency syndrome (AIDS), viral hepatitis, pulmonary tuberculosis. All seven of these EIDs are associated with high incidence and mortality. This book details the imaging techniques, radiological appearance and characteristics of EIDs, and diagnosis and differential diagnosis of EID-related complications. Considering the unique and in some cases only partially understood nature of EIDs, appropriate space is provided in this book for the detailed explanation of the etiology, epidemiology, pathophysiology, clinical symptoms and signs, laboratory tests, clinical diagnosis and differential diagnosis, prevention, treatment, and prognosis of EIDs. As such, it will be a valuable resource for improving the prevention, diagnosis, and treatment of EIDs. Editors Pu-Xuan Lu and Bo-Ping Zhou are professors at Shenzhen Third People's Hospital, Guangdong Medical College, China.
- 2014 Wileyedited by Alberto Signore, MD, PhD, Professor of Nuclear Medicine, Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine and Psychology, "Sapienza" University, Rome, Italy, Ana Maria Quintero, MD, Radiologist, Department of Radiology, Clinica Reina Sofia, Clinica Colsanitas, Bogotá, Colombia.Epidemiology of infections in the new century / Nicola Petrosillo -- Bacterial osteomyelitis : the clinician point of view / Ilker Uçkay, Nicolas Christian Buchs, Khalid Seghrouchni, Mathieu Assal, Pierre Hoffmeyer, and Daniel Lew -- Radiologic imaging of osteomyelitis / Jenny T. Bencardino, Zoraida Restrepo-Velez, Randall Bujan, and Diego Jaramillo -- Radiological evaluation of spine infection / Ana Marøa Quintero and Roy Riascos -- Radiological imaging of soft tissue infections / Carolina Whittle and Giancarlo Schiappacasse -- Radiological imaging of abdominal infection and inflammatory disease / Carolina Whittle, Giancarlo Schiappacasse, and Francesca Maccioni -- Radiological imaging of vascular graft infection / Alejandro Romero, Tobøas Zander, Jorge Lopera, Sergi Quiroga, Manuel Maynar -- Radiological imaging of TB and HIV / Jorge Carrillo -- Nuclear medicine imaging of infections : techniques, acquisition protocol, and interpretation criteria / Alberto Signore -- Nuclear medicine imaging of osteomyelitis : WBC, monoclonal antibody, or bacterial imaging? / Christopher J. Palestro -- Nuclear medicine imaging of spondylodiscitis : the emerging role of PET / Elena Lazzeri, Paola Anna Erba, Martina Sollini, Giuliano Mariani -- Nuclear medicine imaging of soft tissue infections / Bárbara Roxana Morales Klinkert -- Nuclear medicine imaging of infections and inflammatory diseases of the abdomen / Josep Martøn Comøn, Alba Rodrøguez Gasén, and Christophe Van de Wiele -- Nuclear medicine imaging of vascular graft infections : the added role of hybrid imaging / Ora Israel -- Nuclear medicine imaging of TB and HIV / Mike Sathekge, Christophe van de Wiele, and Alberto Signore -- Nuclear medicine imaging in fever of unknown origin / François-Xavier Hanin and François Jamar -- Nuclear medicine imaging of inflammatory diseases / Marco Chianelli, Gaurav Malviya, Andor W.J.M. Glaudemans, and Alberto Signore.
- 2010 ClinicalKey[edited by] Richard L. Kradin."Online and print, this comprehensive, organ-based reference is an invaluable tool for the accurate diagnosis of infectious diseases - from the common to the most challenging." "Integrates the latest techniques in immunohistochemistry and molecular genetics throughout the text for comprehensive information on all investigative contexts relevant to ensuring diagnostic accuracy; Emphasizes the host responses critical in differential diagnosis to serve as a second opinion when non-infectious diagnoses mimic and confound the diagnosis of infection; Provides a complete visual guide to suspect lesions through superb, high-quality, full-color illustrations of key aspects of various diseases that facilitate the rapid identification of biopsy specimen; Features tables that list differential diagnosis for each lesion for quick summaries of key points in problem areas; and Highlights morphological characteristics and landmarks of tissue samples throughout the text for easy access to information necessary for signing out specimens."--BOOK JACKET.
- 2006 NCBI Bookshelfeditors, Dean T. Jamison ... [et al.].
- 2007 CRCnetBASEedited by Gurusamy Manivannan.Perspectives on infection challenges and solutions / Manivannan -- Sisyphus in the microbial world revisited : global governance, antimicrobial strategies, and humanity's health / Fidler -- The need for safer and better microbiocides for infection control / Sattar, Springthorpe -- Microbiological concerns in non-sterile manufacturing / Farrington, Polarine -- New technologies in disinfection and infection control / Ramirez -- Biocides : modes of action and mechanisms of resistance / McDonnell -- A pragmatic approach to judicious selection and proper use of disinfectant and antiseptic agents in healthcare setting / Suljagic -- Extended activity of healthcare antiseptic products / Newman, Kaiser -- Disinfectant rotation in a cleaning/disinfection program for cleanrooms and controlled environments / Sutton -- Reprocessing flexible endoscopes : origin of standards, overview of structure/function, and review of recent outbreaks / Antonucci, Williams, Robinson -- Microbiological testing of disinfectants and decontaminants for critical surfaces / Klein -- Regulatory constraints on disinfectants and decontamination / Sarli -- Biofilms : a summarized account and control strategies / Nandakumar, Sreekumari -- Consequences of biofilms on indwelling medical devices : costs and prevention / Thomas, Nakaishi, Corum -- Infection-resistant implantable devices : biofilm problems and design strategies / Smith, Perera -- Infections of intracardiac devices / Yesenosky ... [et al.] -- Intrauterine devices : infections and biofilms / Pereira, Pruthi -- Antimicrobial urinary catheters / Stickler, Sabbuba -- Risk factors for post-operative infectious complications after abdominal surgery / Pessaux, Lermite.
- 2016 ebrary, Limited to 3 simultaneous usersGuenter B. Risse.
- 2011 SpringerStephen C. Piscitelli, Keith A. Rodvold, Manjunath P. Pai, editors.Introduction to Drug-Drug Interactions -- Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion -- Mechanisms of Drug Interactions II: Transport Proteins -- Drug-Food Interactions -- Interactions Between Herbs and Antiinfective Medications -- Drug-Cytokine Interactions -- Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions with Antiretrovirals for HIV Infection -- Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelmintic Agents -- Drug Interaction Considerations Throughout Drug Development -- Probe Cocktail Studies -- Design and Data Analysis in Drug Interaction Studies.
- 2009 SpringerBruce Hannon, Matthias Ruth.The why and how of dynamic modeling -- Basic epidemic models -- Insect dynamics -- Malaria and sickle cell anemia -- Encephalitis -- Chagas disease -- Lyme disease -- Chicken pox and shingles -- Toxoplasmosis -- The zebra mussel -- Biological control of pestilence -- Indirect susceptible-infected-resistant models of arboviral encephalitis transmission -- Chaos and pestilence -- Catastrophe and pestilence -- Spatial pestilence dynamics.
- 2013 SpringerV. Sree Hari Rao, Ravi Durvasula, editors.This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics --c Source other than Library of Congress.
- 2013 SpringerV. Sree Hari Rao, Ravi Durvasula, editors.This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics.
- 2015The Overview of Needs and Requirements covers the costs of the Ebola response and preparedness activities. The needs and requirements are based on the latest information available from each of the most affected countries. The national plans and budgets comprise the framework and the Overview of Needs and Requirements defines the contributions planed by the UN system as well as the major international civil society organizations.
- 2009 SpringerNicholas Graves, Kate Halton, William Jarvis.
- 2012 WHOChapter 1. Identifying general requirements -- Chapter 2. Identifying detailed requirements -- Chapter 3. Selecting a solution -- Chapter 4. Implementing an electronic recording and reporting system .Also available: Print – 2012
- 2010 Springeredited by Kevin P. O'Connell ... [et al.].Global effects and prevention of emerging and epidemic pathogens: cholera and citrus greening as examples -- Surveillance -- Epidemiological surveillance of highly pathogenic diseases in Kazakhstan -- Surveillance on plague in Natural foci in Georgia -- Application of modern techniques for studying bacterial pathogens in Georgia -- Especially dangerous infections in Azerbaijan -- Strengthening the early-warning function of the surveillance system: the Macedonian experience -- Integrating geographic information systems and ecological niche modeling into disease ecology: a case study of Bacillus anthracis in the United States and Mexico -- Molecular analysis and tools -- Applications of paleomicrobiology to the understanding of emerging and re-emerging infectious diseases -- Characterization of a putative hemagglutinin gene in the caprine model for brucellosis -- Pathoadaptation of especially dangerous pathogens -- Detection of pathogens via high-throughput sequencing -- Environmental infuences on the relative stability of baculoviruses and Vaccinia virus: a review.
- 2013 WileyPrakash S. Bisen and Ruchika Raghuvanshi.A global perspective on the management and prevention of emerging and re-emerging diseases Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse. This book takes a look at the worl
- 2008 Springeredited by Yichen Lu, M. Essex, Bryan Roberts.
- 2013 Future Mededitors, Masao Omata, Tatsuo Kanda.Hepatitis C virus infection : from discovery to eradication / Masao Omata & Tatsuo Kanda -- Interferons in clinical trials / Tatsuo Kanda, Osamu Yokosuka & Masao Omata -- Protease inhibitors / Marion Corouge, Philippe Sogni & Stanislas Pol -- NS5A inhibitor : daclatasvir / Kazuaki Chayama & C. Nelson Hayes -- Toll-like receptor agonists for nonresponders to HCV treatment : hope versus promise? / Valérie Martel-Laferrière & Douglas Dieterich -- Treatment options in HIV-HCV-coinfected patients / Philippe Sogni, Marion Corouge & Stanislas Pol -- Treatment options for dual HCV/HBV coinfection / Chun-Jen Liu & Jia-Horng Kao -- HCV treatment in patients with metabolic syndrome / Luigi E. Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo & Paola Loria -- Future directions in hepatitis C therapy / Stevan A. Gonzalez -- Index.
- 2007 Kargervolume editor, Sunil K. Lal.The Singapore contribution in the battle against the severe acute respiratory syndrome / Fielding, B.C., Tan, Y.-J. -- Avian influenza in Thailand / Puthavathana, P. ... [et al.] -- Emerging viral diseases of fish and shrimp / Wang, M. ... [et al.] -- Avian influenza H5N1 virus: an emerging global pandemic / Lal, S.K., Chow, V.T.K. -- Henipaviruses: new threats for Southeast Asia and Australia / McCormack, J., Smith, G. -- Ross River virus: an arthritogenic alphavirus of significant importance in the Asia Pacific / Tupanceska, D. ... [et al.] -- Emerging and re-emerging infectious diseases in our global village / Heymann, D.L. -- Role of a pathology laboratory in SARS and other emerging infections / Nicholls, J., Peiris, J.S.M. -- The fight against emerging viral diseases in Asia / Lam, S.K.
- 2014 SpringerIan MacKay, Noel R. Rose, editors-in-chief ; Betty Diamond, Anne Davidson, editors.
- 2012 CRCnetBASEedited by William Charney."'Do no harm' a particularly leading and important phrase in the delivery of healthcare is not working. In fact depending on the epidemiological approach and which data sets one applies, medical errors, hospital acquired infections (HAIs) and pharmaceutical errors combined are the second or third leading killer of Americans annually: approximately 300,000 die from a combination of medical errors, hospital acquired infections (HAIs), and pharmaceutical errors...100,000 per category. Add to these numbers the hundreds of thousands who are harmed (morbidity) but not killed (mortality) changing quality of life and a substantial problem is defined"--Provided by publisher.
- 2011 SpringerT. Ramamurthy, S.K. Bhattacharya, editors.Asiatic cholera: mole hills and mountains -- Endemic and epidemic cholera in Africa -- Phenotypic and molecular characteristics of epidemic and non-epidemic vibrio cholerae strains isolated in Russia and certain countries of Commonwealth of Independent States (CIS) -- The re-emergence of cholera in the Americas -- The evolution of vibrio cholerae as a pathogen -- Molecular epidemiology of toxigenic vibrio cholerae -- Diversity and genetic basis of polysaccharide biosynthesis in vibrio cholerae -- Significance of the SXT/R391 family of integrating conjugative elements in vibrio cholerae -- Small molecule signaling systems in vibrio cholerae -- Vibrio cholerae flagellar synthesis and virulence -- Filamentous phages of vibrio cholerae O1 and O139 -- Pathogenic potential of non-O1, non-O139 vibrio cholerae -- Proteases produced by vibrio cholerae and other pathogenic vibrios: pathogenic roles and expression -- Toxins of vibrio cholerae and their role in inflammation, pathogenesis, and immunomodulation -- Vibrio cholerae hemolysin: an enigmatic pore-forming toxin -- Integrin-mediated antimicrobial resistance in vibrio cholerae -- Aquatic realm and cholera -- Management of cholera.
- 2012 SpringerGeorge Pollock.1. Early Concepts of Communicability -- 2. Infection on the Move -- 3. The Impact of Cholera -- 4. Stiffening the Sinews -- 5. Dawn and Sunset -- 6. A Need for Damage Limitation -- 7. No Lasting Stability -- 8. Tailpiece.
- Epidemiology and prevention of vaccine-preventable diseases : the pink book : course textbook. 13th edition.2015 CDCedited by Jennifer Hamborsky, Andrew Kroger, Charles (Skip) Wolfe.
- 2008 Springeredited by Neil S. Skolnik ; associate editor, Ross H. Albert.Part I. Upper Respiratory Tract Infections -- 1. Clinical guidelines: community acquired pneumonia / John Russell -- 2. Pharyngitis / Adrian Wilson -- 3. Treatment and management of acute otitis media / Ross H. Albert and Neil S. Skolnik -- 4. Management of chronic obstructive pulmonary disease exacerbations and acute bronchitis / Michael Gagnon -- 5. Latent tuberculosis infection: testing and treatment / Pamela Ann Fenstemacher -- 6. Sinusitis / Megan Werner and Mathew Clark -- Part II. Gastrointestinal Infections -- 7. Gastroenteritis / Andrew Deroo and Matthew Mintz -- 8. Hepatitis / Michele Lamoreux -- III. Sexually Transmitted Diseases -- 9. Sexually transmitted diseases / Neil Skolnik -- 10. Human immunodeficiency virus / Rosemary Harris -- IV. Skin, Bone, and Joint Infection -- 11. Cellulitis and skin infections associated with bites / Steven Zinn and Judith O'Donnell -- 12. Diabetic foot infections / Thomas C. McGinley Jr. -- 13, Osteomyelitis / Kelly Gannon and Todd Braun -- 14. Septic arthritis and infectious bursitis / Gene Hong and Nirandra Mahamitra -- 15. Lyme disease prevention, diagnosis, and treatment / Ross Albert and Neil Skolnik -- V. Other Infectious Disease Topics -- 16. Infective endocarditis / Tina Degnan and Neil Skolnik -- 17. Meningitis / Anne T. Wiedemann -- 18. Urinary tract infections / Jennifer Neria and Matthew Mintz -- 19. Adult immunizations / John Russell and Ross Albert -- 20. Clinical ethics and infectious disease in family medicine / Janet Fleetwood.
- 2015 Wileyedited by Jane N. Zuckerman, Gary W. Brunette, Peter A. Leggat.Basic epidemiology of infectious diseases / Mark J. Sotir and David O. Freedman -- Basic epidemiology of non-infectious diseases / Richard C. Franklin and Peter A. Leggat -- Pre-travel health risk assessment / Peter A. Leggat and Jane N. Zuckerman -- Setting up a travel clinic -- Marc T.M. Shaw and Claire S. Wong -- Travel medicine resources / Peter A. Leggat, Gary W. Brunette, Gilles Poumerol and Jane N. Zuckerman -- Travellers' diarrhoea / Charles D. Ericsson -- Vector borne diseases / Annelies Wilder-Smith -- Yellow fever / Mark D. Gershman and J. Erin Staples -- Malaria / Tomas Jelinek -- Respiratory disease and travel / Regina Larocque and Edward T. Ryan -- Sexually transmitted infections in travellers / Alberto Matteelli, Anna Cristina Carvalho and Patricia Schlagenhauf -- Tropical skin infections / Fransisco Vega-Lopez and Sara Ritchie -- Rabies / Mary Warrell -- Vaccine-preventable disease / Joseph Torresi, Abinash Virk and Jane N. Zuckerman -- Women's health and travel / I. Dale Carroll -- Children's health and travel / Karl Newman and Phil Fischer -- Travelers with underlying medical conditions / Anne McCarthy and Kathy Suh -- The older traveler and traveling with disability / Kathy Suh and Anne McCarthy -- Visiting friends and relatives / Karin Leder and Sarah McGuinness -- Migrants, refugees and travel medicine / Louis Loutan -- Study-abroad programs : student health and safety issues / Gary Rhodes and Gary W. Brunette -- Humanitarian aid workers, disaster relief workers, and missionaries / Brian D. Gushulak and Douglas W. MacPherson -- Long-term travelers / Claire Davies and Ted Lankester -- Aviation and travel medicine / Michael Bagshaw, Ian Cheng and Robert Bor -- Expedition and wilderness medicine / Sean Hudson, Will Smith, David Shlim, Caroline Knox, Karen Marienau -- Scuba and diving medicine / Karen J. Marienau -- Venomous and poisonous animals and toxins / Mark A. Read -- Cruise ships and travel medicine / Sally S.J. Bell and Eilif Dahl -- Mass gatherings and travel medicine / Joanna Gaines and Gary W. Brunette -- Emergency care whilst abroad / Peter A. Leggat and Marc T.M. Shaw -- The returning traveller / Tamar Lachish, Fons Van Gompel and Eli Schwartz.
- 2014 WileyDavid Isaacs.How to search for evidence -- Epidemiology -- Clinical manifestations -- Laboratory tests -- Rational antibiotic use -- Adjunctive treatment -- Bacterial meningitis -- Respiratory tract infections -- Osteomyelitis and septic arthritis -- Urinary tract infections -- Necrotizing enterocolitis and gastrointestinal infections -- Eye infections -- Skin and soft tissue infections -- Bacterial infections -- Mycoplasmas -- Fungal infections -- Viral infections -- Other congenital infections -- Breast milk -- Surveillance -- Infection control -- Developing countries -- Prevention of neonatal infections -- Neonatal antimicrobials.
- 2015Gail Jarrow.Status: Not Checked OutLane Catalog RecordChronicles the story of the early 1900s typhoid fever epidemic in New York, providing details as to how its infamous carrier was ultimately tracked down and stopped.-- (Source of description not identified)
- 2014 ClinicalKey[edited by] James D. Cherry, Gail J. Harrison, Sheldon L. Kaplan, William J. Steinbach, Peter Hotez.Feigin and Cherry's Textbook of Pediatric Infectious Diseases helps you put the very latest knowledge to work for your young patients with unparalleled coverage of everything from epidemiology, public health, and preventive medicine through clinical manifestations, diagnosis, treatment, and much more. Ideal for all physicians, whether in an office or hospital setting, Feigin and Cherry's equips you with trusted answers to your most challenging clinical infectious disease questions. Meet your most difficult clinical challenges in pediatric infectious disease, including today's more aggressive infectious and resistant strains as well as emerging and re-emerging diseases, with unmatched, comprehensive coverage of immunology, epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. Find the answers you need quickly thanks to an organization both by organ system and by etiologic microorganism, allowing you to easily approach any topic from either direction. Search the complete text and download all of the images online at Expert Consult.
- Fomites in infectious disease transmission : a modeling, laboratory, and field study on microbial transfer between skin and surfaces2010Timothy Ryan Julian.This dissertation examines the factors that influence fomite-mediated (e.g., indirect contact) transmission of viral gastrointestinal and respiratory illness. Specifically, the dissertation investigates virus transfer between surfaces and virus recovery from surfaces, models human-fomites interactions to estimate exposure and infection risk, and elucidates causal links between microbial contamination and illness in child care centers. Indirect contact transmission refers to person-to-person transmission of disease via an intermediate fomite (e.g., inanimate object acting as a carrier of infectious disease). The role of indirect contact in disease spread is poorly understood in part because the transmission route of viral pathogens is often difficult to determine. Transmission of respiratory and gastrointestinal viruses can occur through multiple routes (e.g., direct contact, indirect contact, airborne, and common vehicle), and the relative contribution of each route to total disease burden is unclear. The first study in this dissertation examines virus transfer between skin and surfaces, a necessary step in fomite-mediated transmission of viral disease. In the study, transfer of virus between fingerpads and fomites is explored in a laboratory setting. Bacteriophage (fr, MS2, and PHIX174) are used as proxies for pathogenic virus, and over 650 unique transfer events are collected from 20 different volunteers. The study concludes that approximately one quarter (23%) of recoverable virus is readily transferred from a contaminated surface (e.g., a fomite) to an uncontaminated surface (e.g., a finger) on contact. Using the large data set, the direction of transfer (from fingerpads-to-fomite or fomite-to-fingerpad) and virus species are demonstrated to both significantly influence the fraction of virus transferred by approximately 2-5%. To investigate the relative importance of factors contributing to fomite-mediated transmission, a child's risk of illness from exposure to a contaminated fomite is modeled. Specifically, the model estimates a child's exposure to rotavirus using a stochastic-mechanistic framework. Simulations of a child's contacts with the fomite include intermittent fomite-mouth, hand-mouth, and hand-fomite contacts based on activities of a typical child under six years of age. In addition to frequency of contact data, parameters estimated for use in the model include virus concentration on surface; virus inactivation rates on hands and the fomite; virus transfer between hands, fomite, and the child's mouth; and the surface area of objects and hands in contact. From the model, we conclude that a child's median ingested dose from interacting with a rotavirus-contaminated ball ranges from 2 to 1,000 virus over a period of one hour, with a median value of 42 virus. These results were heavily influenced by selected values of model parameters, most notably, the concentration of rotavirus on fomite, frequency of fomite-mouth contacts, frequency of hand-mouth contacts, and virus transferred from fomite to mouth. The model demonstrated that mouthing of fomite is the primary exposure route, with hand mouthing contributions accounting for less than one-fifth of the child's dose over the first 10 minutes of interaction. Based on the findings from the model that concentration of virus on a fomite influences a child's risk of illness, we investigate methods to recover virus from fomites. In a literature review and subsequent meta analysis, we demonstrate that the outcome currently used to describe virus contamination, positivity rate, is biased by the authors' selected sampling methods. We follow up, in the laboratory, with a comparison of the identified methods and demonstrate that polyester-tipped swabs prewetted in 1/4-strength Ringer's solution or saline solution is the most efficient sampling method for virus recovery tested. The recommended method is compatible with plaque assay and quantitative reverse-transcription polymerase chain reaction, two techniques used to quantify virus. The link between hand / fomite contamination and infection risk was explored in a field study at two child care centers over four months. Both respiratory and gastrointestinal disease incidence were tracked daily, while hand and environmental surface contamination were monitored weekly between February 2009 and June 2009. Microbial contamination was determined using quantitative densities of fecal indicator bacteria (e.g. Escherichia coli, enterococci, and fecal coliform) on hands and fomites as well as presence/absence of viral pathogens (e.g. enterovirus and norovirus). Health was monitored daily by childcare staff, who tracked absences, illness-related absences, and symptomatic respiratory and gastrointestinal illness. The resultant data suggests that increases in microbial contamination led to increases in symptomatic respiratory illness four to six days later, in agreement with typical incubation periods for respiratory illness. Similarly, respiratory illness led to increases in microbial contamination on hands during presentation of symptoms, and on fomites in the following three days.
- 2008 WHOWorld Health Organization."These guidelines have been written for public health practitioners, food and health inspectors, district and national medical officers, laboratory personnel and others who may undertake or participate in the investigation and control of foodborne disease outbreaks."--P. 4 of cover.Also available: Print – 2008
- 2003 Wellcome Trustedited by L.A. Reynolds and E.M. Tansey.
- 2013 SpringerPeter Zuber.This SpringerBrief on Spx reviews the investigations that led to the discovery of Spx and its orthologs and ties together the results of various studies that have explored the function and control of spx in Gram-positive organisms. Spx of Bacillus subtilis has been extensively studied, but very little has been published about it. This book incorporates a number of studies that have been conducted in other Gram positive bacteria, which examined the role of Spx orthologs in stress response, bacterial development and virulence. The book contains an overview that will introduce the protein and its orthologous forms, its association with RNA polymerase, the species of Gram-positive bacteria in which it is found, and the conditions in which it is abundant and active. Spx is a member of a large group of proteins belonging to the ArsC/Spx protein family, so the review touches upon the bioinformatic support for the protein family composition and its meaning with regard to protein structure/function.
- 2014 Springeredited by Alexander Vinks, Hartmut Derendorf, Johan Mouton.Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in making predictions under new or changing pre-clinical and clinical circumstances. Not surprisingly, pharmacokinetic-pharmacodynamic modeling concepts are increasingly applied in both basic and clinical research as well as in drug development. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics is designed as a reference on the application of pharmacokinetic-pharmacodynamic principles for the optimization of antimicrobial therapy, namely pharmacotherapy, and infectious diseases. The reader is introduced to various aspects of the fundamentals of antimicrobial pharmacodynamics, the integration of pharmacokinetics with pharmacodynamics for all major classes of antibiotics, from basic research to clinical situations.
- 2013[edited by] James W. Myers, Jonathan P. Moorman, Cassandra D. Salgado.Status: Not Checked OutLane Catalog Record
- 2012 Ovideditors, Matthew E. Falagas, Eleftherios Mylonakis."Using the two-page, templated organization of the 5-Minute Consult series, Gorbach's 5-Minute Infectious Diseases Consult, Second Edition provides comprehensive coverage for clinicians dealing with infectious diseases. The two major sections of the book cover chief complaints and individual diseases and disorders. Additional materials include summary information about individual microorganisms as well as numerous elements related to drugs for infectious disorders. A team of international authorities provides actionable information, supported by current research and practice guidelines.Features Include: Comprehensive coverage of infectious diseases, important symptoms, microorganisms, and anti-infective drugs Coverage of emerging infectious diseases such as H1N1 flu Increased coverage of tropical diseases Two-page, tightly written chapters Updated information about management of HIV/AIDS "--Provided by publisher.
- 2005 Springeredited by S.H.E. Kaufmann and P.-H. Lambert.
- 2014 CRCnetBASERonald M. Atlas, James W. Snyder."Preface Almost 1,800 media are described in the Handbook of Media for Clinical and Public Health Microbiology, including newly described media for the cultivation of emerging pathogens. Diseases caused by emerging pathogens that are responsible for increased rates of morbidity and mortality rates, such as Escherichia coli O157:H7, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant enterococci (VRE), and carbapenem resistant enterococci (CRE) have raised special concerns and various media included in the Handbook have been designed for the specific cultivation and identification of these pathogens. Many of the new media included in the Handbook of Media for Clinical and Public Health Microbiology permit the cultivation of bacteria, fungi, and viruses that are currently causing major medical problems around the world. These media are very important for the rapid detection of pathogenic microorganisms and the diagnosis of individuals with specific infectious diseases adn for preventing the spread of pathogens via food, water, and environmental sources. Several of the new media described in the Handbook of Media for Clinical and Public Health Microbiology include chromogenic or fluorogenic substrates that permit the rapid detection of specific pathogens. An important function of the Handbook of Media for Clinical and Public Health Microbiology is to provide descriptions of the media that are used to cultivate and identify microorganisms from clinical specimens and those of public health significance. The Handbook provides a compilation of the formulations, methods of preparation, and applications for media used in clinical and public health microbiology laboratories"--Provided by publisher.
- 2016 SpringerIan Feavers, Andrew J Pollard, Manish Sadarangani [editors].Introduction and epidemiology of meningococcal disease -- Carriage and transmission of meningitis -- Pathogenesis of meningitis -- Diagnosis of meningococcal disease -- Clinical aspects of meningitis -- Treatment of meningococcal disease -- Prevention of meningococcal disease -- Appendix.
- Achieving an AIDS transition : preventing infections to sustain treatment — Handbook of meningococcal disease management (100)
- HCV infection and cryoglobulinemia — New and evolving infections of the 21st century (100)
- New frontiers of molecular epidemiology of infectious diseases — World malaria report 2009 (79)
- Harrison's Principles of Internal Medicine
- AAP Red Book Online
- Robbins & Cotran Pathologic Basis of Disease
- Sabiston Textbook of Surgery
- Nelson's Textbook of Pediatrics
- Surgical Exposures in Orthopaedics
- Mandell, Douglas, & Bennett's Principles & Practice of Infectious Diseases
- Red Book Online
- ICU Book
- Primary Care Medicine
- Campbell-Walsh Urology
Access restricted to Stanford community
Shortcut to Licensed Content
TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.
Bookmark on Other Websites
- TO INSTALL, RIGHT CLICK this button.
- Select "Add to Favorites" (click “Continue” if you see a security alert)
- From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
- Once installed it will look like this
- Click "Bookmark on Lane" to bookmark any webpage
- Your saved bookmark will appear on this page
Can't find it?
Look if we have it in print
- Springer Protocols
- Lange Series
- National Academy Press
- NCBI Bookshelf
- Thieme Atlases
A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.
Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed is a clinical information resource used by physicians to answer clinical questions quickly and easily at the point of care. Topics are updated daily as new evidence becomes available.Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialtiesProvides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.
Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.
Includes cited reference searching, citation maps, and an analyze tool.
Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.
Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.
Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.
In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.
A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.
Over 10,000 notes outline the status of specific infections within each country.
Provides online, full-text access to Springer's journal titles as well as journals from other publishers.
Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.